CN118930533A - 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 - Google Patents
被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 Download PDFInfo
- Publication number
- CN118930533A CN118930533A CN202410345199.5A CN202410345199A CN118930533A CN 118930533 A CN118930533 A CN 118930533A CN 202410345199 A CN202410345199 A CN 202410345199A CN 118930533 A CN118930533 A CN 118930533A
- Authority
- CN
- China
- Prior art keywords
- methyl
- pyrazole
- thiazol
- carboxylic acid
- isopropylsulfanyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title abstract description 79
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 51
- 230000003463 hyperproliferative effect Effects 0.000 title abstract description 20
- 201000010099 disease Diseases 0.000 title description 24
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical class C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 480
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 256
- 229910052757 nitrogen Inorganic materials 0.000 claims description 145
- 125000000217 alkyl group Chemical group 0.000 claims description 84
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 79
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 78
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 73
- 229910052739 hydrogen Inorganic materials 0.000 claims description 73
- 229910052799 carbon Inorganic materials 0.000 claims description 48
- 125000003118 aryl group Chemical group 0.000 claims description 47
- 125000001072 heteroaryl group Chemical group 0.000 claims description 47
- 125000001424 substituent group Chemical group 0.000 claims description 43
- 125000003342 alkenyl group Chemical group 0.000 claims description 35
- 229910052736 halogen Inorganic materials 0.000 claims description 33
- 150000002367 halogens Chemical class 0.000 claims description 33
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 28
- 229910052760 oxygen Inorganic materials 0.000 claims description 26
- 229910052717 sulfur Chemical group 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 24
- 125000005842 heteroatom Chemical group 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 23
- 239000001301 oxygen Chemical group 0.000 claims description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- 125000000304 alkynyl group Chemical group 0.000 claims description 20
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 18
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 17
- 150000001204 N-oxides Chemical class 0.000 claims description 17
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 17
- 239000011593 sulfur Chemical group 0.000 claims description 17
- 239000012453 solvate Substances 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 13
- 125000004650 C1-C8 alkynyl group Chemical group 0.000 claims description 12
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 121
- 201000011510 cancer Diseases 0.000 abstract description 83
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract description 61
- 108010024636 Glutathione Proteins 0.000 abstract description 31
- 229960003180 glutathione Drugs 0.000 abstract description 30
- 230000022131 cell cycle Effects 0.000 abstract description 21
- 101150105104 Kras gene Proteins 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 238000003786 synthesis reaction Methods 0.000 abstract description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 201
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 178
- -1 methoxyethyl Chemical group 0.000 description 141
- 239000000243 solution Substances 0.000 description 139
- 210000004027 cell Anatomy 0.000 description 133
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 131
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 102
- 235000019439 ethyl acetate Nutrition 0.000 description 95
- 239000011541 reaction mixture Substances 0.000 description 89
- 239000003921 oil Substances 0.000 description 86
- 235000019198 oils Nutrition 0.000 description 86
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 80
- 239000000203 mixture Substances 0.000 description 79
- 239000007787 solid Substances 0.000 description 75
- 238000005160 1H NMR spectroscopy Methods 0.000 description 69
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 66
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 62
- 238000006243 chemical reaction Methods 0.000 description 62
- 239000000047 product Substances 0.000 description 58
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- 239000012043 crude product Substances 0.000 description 57
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 52
- 239000011521 glass Substances 0.000 description 51
- 239000000741 silica gel Substances 0.000 description 51
- 229910002027 silica gel Inorganic materials 0.000 description 51
- 239000011734 sodium Substances 0.000 description 51
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 50
- 125000003709 fluoroalkyl group Chemical group 0.000 description 49
- 239000003054 catalyst Substances 0.000 description 48
- 238000003818 flash chromatography Methods 0.000 description 48
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- 239000012044 organic layer Substances 0.000 description 40
- 229910002092 carbon dioxide Inorganic materials 0.000 description 35
- 238000012360 testing method Methods 0.000 description 35
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 31
- 239000010410 layer Substances 0.000 description 28
- 239000002904 solvent Substances 0.000 description 28
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 27
- 239000012267 brine Substances 0.000 description 26
- 208000035475 disorder Diseases 0.000 description 26
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 26
- KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 238000004108 freeze drying Methods 0.000 description 24
- 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 23
- 102100030708 GTPase KRas Human genes 0.000 description 22
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 21
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 20
- 206010025323 Lymphomas Diseases 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- WGHNTAIAYWABNC-UHFFFAOYSA-N methyl 4-bromo-2-(4-bromo-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)Br)SC(C)C)C WGHNTAIAYWABNC-UHFFFAOYSA-N 0.000 description 19
- 239000012071 phase Substances 0.000 description 19
- 230000005855 radiation Effects 0.000 description 19
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 18
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 description 17
- 239000008194 pharmaceutical composition Substances 0.000 description 17
- 229920006395 saturated elastomer Polymers 0.000 description 17
- 229940125904 compound 1 Drugs 0.000 description 16
- 238000005259 measurement Methods 0.000 description 16
- 239000000546 pharmaceutical excipient Substances 0.000 description 16
- 102000016914 ras Proteins Human genes 0.000 description 16
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 15
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 15
- 229940125878 compound 36 Drugs 0.000 description 15
- 125000001153 fluoro group Chemical group F* 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 108010014186 ras Proteins Proteins 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 125000003226 pyrazolyl group Chemical group 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 13
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 12
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000000460 chlorine Substances 0.000 description 12
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 12
- 125000004076 pyridyl group Chemical group 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 229940125797 compound 12 Drugs 0.000 description 11
- 230000002503 metabolic effect Effects 0.000 description 11
- 125000002950 monocyclic group Chemical group 0.000 description 11
- 238000012856 packing Methods 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 10
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 10
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 9
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 9
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 9
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 9
- 201000005787 hematologic cancer Diseases 0.000 description 9
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 9
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 9
- 201000002528 pancreatic cancer Diseases 0.000 description 9
- 208000008443 pancreatic carcinoma Diseases 0.000 description 9
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 8
- 230000035519 G0 Phase Effects 0.000 description 8
- 230000010190 G1 phase Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- 108700020796 Oncogene Proteins 0.000 description 8
- 206010035226 Plasma cell myeloma Diseases 0.000 description 8
- 125000002947 alkylene group Chemical group 0.000 description 8
- 230000006369 cell cycle progression Effects 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 125000000842 isoxazolyl group Chemical group 0.000 description 8
- 208000020816 lung neoplasm Diseases 0.000 description 8
- 125000002757 morpholinyl group Chemical group 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 8
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 230000004663 cell proliferation Effects 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940125807 compound 37 Drugs 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- 231100000673 dose–response relationship Toxicity 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 125000002541 furyl group Chemical group 0.000 description 7
- 125000002883 imidazolyl group Chemical group 0.000 description 7
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 7
- 201000005202 lung cancer Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 125000004193 piperazinyl group Chemical group 0.000 description 7
- 125000003386 piperidinyl group Chemical group 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 125000000335 thiazolyl group Chemical group 0.000 description 7
- 125000001544 thienyl group Chemical group 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 7
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 6
- AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 description 6
- RZUUMJDXFHDWFC-UHFFFAOYSA-N 2-chloro-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CSC(Cl)=N1 RZUUMJDXFHDWFC-UHFFFAOYSA-N 0.000 description 6
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 6
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 206010009944 Colon cancer Diseases 0.000 description 6
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 6
- WTVSHVQCCIIYEB-UHFFFAOYSA-N [2-oxo-2-[4-(trifluoromethyl)phenyl]ethyl] thiocyanate Chemical compound FC(F)(F)C1=CC=C(C(=O)CSC#N)C=C1 WTVSHVQCCIIYEB-UHFFFAOYSA-N 0.000 description 6
- 229960004308 acetylcysteine Drugs 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 125000004450 alkenylene group Chemical group 0.000 description 6
- 125000004419 alkynylene group Chemical group 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 6
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 6
- 125000002619 bicyclic group Chemical group 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical compound C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- MXFYYFVVIIWKFE-UHFFFAOYSA-N dicyclohexyl-[2-[2,6-di(propan-2-yloxy)phenyl]phenyl]phosphane Chemical compound CC(C)OC1=CC=CC(OC(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 MXFYYFVVIIWKFE-UHFFFAOYSA-N 0.000 description 6
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 6
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 6
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 6
- 208000032839 leukemia Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000003760 magnetic stirring Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 201000000050 myeloid neoplasm Diseases 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 125000000714 pyrimidinyl group Chemical group 0.000 description 6
- 230000009257 reactivity Effects 0.000 description 6
- 230000008672 reprogramming Effects 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 6
- 229930192474 thiophene Natural products 0.000 description 6
- OVCXRBARSPBVMC-UHFFFAOYSA-N triazolopyridine Chemical compound C=1N2C(C(C)C)=NN=C2C=CC=1C=1OC=NC=1C1=CC=C(F)C=C1 OVCXRBARSPBVMC-UHFFFAOYSA-N 0.000 description 6
- 235000019143 vitamin K2 Nutrition 0.000 description 6
- 239000011728 vitamin K2 Substances 0.000 description 6
- 229940041603 vitamin k 3 Drugs 0.000 description 6
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 5
- MLSNDRFHLFUGRU-UHFFFAOYSA-N 2-chloro-5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound ClC=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C MLSNDRFHLFUGRU-UHFFFAOYSA-N 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 5
- 208000003950 B-cell lymphoma Diseases 0.000 description 5
- FRYRJNHMRVINIZ-UHFFFAOYSA-N B1CCOO1 Chemical compound B1CCOO1 FRYRJNHMRVINIZ-UHFFFAOYSA-N 0.000 description 5
- 208000011691 Burkitt lymphomas Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 5
- FINPLSBBDVRBPA-UHFFFAOYSA-M chloropalladium(1+);dicyclohexyl-[2-[2,6-di(propan-2-yloxy)phenyl]phenyl]phosphane;2-methoxy-2-methylpropane;2-phenylethanamine Chemical compound [Pd+]Cl.COC(C)(C)C.NCCC1=CC=CC=[C-]1.CC(C)OC1=CC=CC(OC(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 FINPLSBBDVRBPA-UHFFFAOYSA-M 0.000 description 5
- 239000007859 condensation product Substances 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 150000004677 hydrates Chemical class 0.000 description 5
- 125000001041 indolyl group Chemical group 0.000 description 5
- 238000010829 isocratic elution Methods 0.000 description 5
- 125000002971 oxazolyl group Chemical group 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 125000000168 pyrrolyl group Chemical group 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- YTSYITZBAHXPFA-UHFFFAOYSA-N 2-[5-(3,4-dichlorophenyl)-1-(2-methylpropyl)-1,2,4-triazol-3-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1CC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C YTSYITZBAHXPFA-UHFFFAOYSA-N 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 4
- 108010058546 Cyclin D1 Proteins 0.000 description 4
- 102000006311 Cyclin D1 Human genes 0.000 description 4
- 108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 description 4
- 102000000577 Cyclin-Dependent Kinase Inhibitor p27 Human genes 0.000 description 4
- LZAZXBXPKRULLB-UHFFFAOYSA-N Diisopropyl disulfide Chemical compound CC(C)SSC(C)C LZAZXBXPKRULLB-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 101710113436 GTPase KRas Proteins 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 208000003445 Mouth Neoplasms Diseases 0.000 description 4
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 4
- 208000033755 Neutrophilic Chronic Leukemia Diseases 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- XNQRCEKJJKLNRR-UHFFFAOYSA-N [5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]hydrazine Chemical compound N(N)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C XNQRCEKJJKLNRR-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000007900 aqueous suspension Substances 0.000 description 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 201000010903 chronic neutrophilic leukemia Diseases 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 125000001786 isothiazolyl group Chemical group 0.000 description 4
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 4
- SFTZRUZMNGBFFL-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)cyclohexen-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CCC(CC1)C(F)(F)F)SC(C)C)C SFTZRUZMNGBFFL-UHFFFAOYSA-N 0.000 description 4
- LJIPTQAYPRGZFQ-UHFFFAOYSA-N methyl 5-oxo-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-1H-pyrazole-3-carboxylate Chemical compound OC1=NN(C(=C1)C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C LJIPTQAYPRGZFQ-UHFFFAOYSA-N 0.000 description 4
- 201000005962 mycosis fungoides Diseases 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000006574 non-aromatic ring group Chemical group 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000003373 pyrazinyl group Chemical group 0.000 description 4
- 150000003230 pyrimidines Chemical group 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 206010041823 squamous cell carcinoma Diseases 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- 125000001113 thiadiazolyl group Chemical group 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- HEMROKPXTCOASZ-UHFFFAOYSA-N 2-bromo-1-[4-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC=C(C(=O)CBr)C=C1 HEMROKPXTCOASZ-UHFFFAOYSA-N 0.000 description 3
- FWJRSOGVYOIVOC-UHFFFAOYSA-N 2-methylprop-1-enylboronic acid Chemical compound CC(C)=CB(O)O FWJRSOGVYOIVOC-UHFFFAOYSA-N 0.000 description 3
- RUKDVLFJSMVBLV-UHFFFAOYSA-N 5-iodo-1h-pyrazole Chemical compound IC1=CC=NN1 RUKDVLFJSMVBLV-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 208000004736 B-Cell Leukemia Diseases 0.000 description 3
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 3
- 208000006168 Ewing Sarcoma Diseases 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000017604 Hodgkin disease Diseases 0.000 description 3
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 3
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
- 240000007472 Leucaena leucocephala Species 0.000 description 3
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 description 3
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 description 3
- 206010028811 Natural killer-cell leukaemia Diseases 0.000 description 3
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 3
- 102000043276 Oncogene Human genes 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 3
- 206010042971 T-cell lymphoma Diseases 0.000 description 3
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 3
- 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 3
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 3
- 208000017733 acquired polycythemia vera Diseases 0.000 description 3
- 208000015230 aggressive NK-cell leukemia Diseases 0.000 description 3
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 3
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 201000010902 chronic myelomonocytic leukemia Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 3
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 3
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- LZWLLMFYVGUUAL-UHFFFAOYSA-L ditert-butyl(cyclopenta-1,3-dien-1-yl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1 LZWLLMFYVGUUAL-UHFFFAOYSA-L 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 230000034659 glycolysis Effects 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 3
- 208000026876 intravascular large B-cell lymphoma Diseases 0.000 description 3
- 230000000155 isotopic effect Effects 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- JCQKUVDBWSNAHV-UHFFFAOYSA-N methyl 2-(4-bromo-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)-5-methylpyrazole-3-carboxylate Chemical compound BrC=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)OC)C JCQKUVDBWSNAHV-UHFFFAOYSA-N 0.000 description 3
- LRWUQSQTHXGSHK-UHFFFAOYSA-N methyl 4-bromo-2-[4-bromo-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)Br)C1=CC=C(C=C1)C(F)(F)F)C LRWUQSQTHXGSHK-UHFFFAOYSA-N 0.000 description 3
- CPCASXXNKDDMGL-UHFFFAOYSA-N methyl 4-iodo-2-[5-iodo-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound IC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)I)C CPCASXXNKDDMGL-UHFFFAOYSA-N 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 125000005322 morpholin-1-yl group Chemical group 0.000 description 3
- 231100000590 oncogenic Toxicity 0.000 description 3
- 230000002246 oncogenic effect Effects 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 208000037244 polycythemia vera Diseases 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 3
- 229940116357 potassium thiocyanate Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 3
- 230000005740 tumor formation Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- KAAHYYXTPCRKIT-UHFFFAOYSA-N (4-bromo-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)hydrazine Chemical compound BrC=1N=C(SC=1SC(C)C)NN KAAHYYXTPCRKIT-UHFFFAOYSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 2
- MXACZLIQEYYSHM-UHFFFAOYSA-N 2-[4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CCC2(OCCO2)CC1)SC(C)C)C MXACZLIQEYYSHM-UHFFFAOYSA-N 0.000 description 2
- HWXYPWMAHVCBJM-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-fluoro-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1F)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C HWXYPWMAHVCBJM-UHFFFAOYSA-N 0.000 description 2
- ZCVPQQUCFNXFNZ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C ZCVPQQUCFNXFNZ-UHFFFAOYSA-N 0.000 description 2
- ZYHABNFDFIHEFJ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[3-methyl-5-(oxetan-3-yloxy)phenyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)OC1COC1)C)C ZYHABNFDFIHEFJ-UHFFFAOYSA-N 0.000 description 2
- WWQFHKYCDFDXOY-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)-3,5-dimethylpyrazol-1-yl]-5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C)-c1cccc(F)c1 WWQFHKYCDFDXOY-UHFFFAOYSA-N 0.000 description 2
- VBNPMHGEOJTKAD-UHFFFAOYSA-N 2-[4-(4-acetylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)(=O)N1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C VBNPMHGEOJTKAD-UHFFFAOYSA-N 0.000 description 2
- CCNGVHKBAFQHLJ-UHFFFAOYSA-N 2-[4-(4-cyanopiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C CCNGVHKBAFQHLJ-UHFFFAOYSA-N 0.000 description 2
- LULUEXOUOGDMHT-UHFFFAOYSA-N 2-[4-(4-cyclopropylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C1(CC1)N1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C LULUEXOUOGDMHT-UHFFFAOYSA-N 0.000 description 2
- HZCITNCAZYWLFW-UHFFFAOYSA-N 2-[4-(4-ethylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)N1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C HZCITNCAZYWLFW-UHFFFAOYSA-N 0.000 description 2
- KYQAWTUXPJTFKH-UHFFFAOYSA-N 2-[4-[4-chloro-2-(oxetan-3-yloxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=CC(=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)O)C)OC1COC1 KYQAWTUXPJTFKH-UHFFFAOYSA-N 0.000 description 2
- CGGOKPPVHPSIDS-UHFFFAOYSA-N 2-[4-[4-chloro-3-(morpholine-4-carbonyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C(=O)N1CCOCC1 CGGOKPPVHPSIDS-UHFFFAOYSA-N 0.000 description 2
- RASYQZCHAFQHCZ-UHFFFAOYSA-N 2-[4-[4-chloro-3-(oxetan-3-yloxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)O)C)OC1COC1 RASYQZCHAFQHCZ-UHFFFAOYSA-N 0.000 description 2
- IZOWAHGCABJRPE-UHFFFAOYSA-N 2-chloro-5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazole Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NN=C(Cl)S1 IZOWAHGCABJRPE-UHFFFAOYSA-N 0.000 description 2
- MGHXSDXCZSBYLE-UHFFFAOYSA-N 2-chloro-5-propan-2-ylsulfanyl-1,3-thiazole Chemical compound ClC=1SC(=CN=1)SC(C)C MGHXSDXCZSBYLE-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- VEDIADQJSGNNQE-UHFFFAOYSA-N 3,4-dichlorobenzohydrazide Chemical compound NNC(=O)C1=CC=C(Cl)C(Cl)=C1 VEDIADQJSGNNQE-UHFFFAOYSA-N 0.000 description 2
- PXBCDCSAGJKYRU-UHFFFAOYSA-N 3-(2-bromo-5-chlorophenoxy)oxetane Chemical compound BrC1=C(OC2COC2)C=C(C=C1)Cl PXBCDCSAGJKYRU-UHFFFAOYSA-N 0.000 description 2
- XCNZAQLVBCCHIY-UHFFFAOYSA-N 3-(5-bromo-2-chlorophenoxy)oxetane Chemical compound BrC=1C=CC(=C(OC2COC2)C=1)Cl XCNZAQLVBCCHIY-UHFFFAOYSA-N 0.000 description 2
- DDAWNNRBFJLRGT-UHFFFAOYSA-N 3-[2-[4-(3-fluorophenyl)-5-methoxycarbonyl-3-methylpyrazol-1-yl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]propanoic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CCC(=O)O)C DDAWNNRBFJLRGT-UHFFFAOYSA-N 0.000 description 2
- GBUOPKAGDIQVTN-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-[4-(2-phenylethynyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC1=NC(=CC(=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C#CC1=CC=CC=C1)SC(C)C)C)C GBUOPKAGDIQVTN-UHFFFAOYSA-N 0.000 description 2
- OTVZZJAIAXAJJW-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(2-hydroxyethyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CCO)C OTVZZJAIAXAJJW-UHFFFAOYSA-N 0.000 description 2
- ANQVCHHDHFBBAZ-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[2-methoxyethyl(methyl)amino]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)N(C)CCOC)C ANQVCHHDHFBBAZ-UHFFFAOYSA-N 0.000 description 2
- IJQRHSAKBFZNHE-UHFFFAOYSA-N 4-(3-fluorophenyl)-3,5-dimethyl-1H-pyrazole Chemical compound FC=1C=C(C=CC=1)C=1C(=NNC=1C)C IJQRHSAKBFZNHE-UHFFFAOYSA-N 0.000 description 2
- SNBQDCGHBOLWJC-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methoxy-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)OC SNBQDCGHBOLWJC-UHFFFAOYSA-N 0.000 description 2
- SVGCXHNDQRLAOX-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-(4-morpholin-4-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCOCC1)SC(C)C)C SVGCXHNDQRLAOX-UHFFFAOYSA-N 0.000 description 2
- GOUOYBYVARLAMY-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-(4-piperidin-1-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCCCC1)SC(C)C)C GOUOYBYVARLAMY-UHFFFAOYSA-N 0.000 description 2
- MZRSBBMZOWCXQT-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(2-methylprop-1-enyl)-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=C(C)C)C1=CC=C(C=C1)C(F)(F)F)C MZRSBBMZOWCXQT-UHFFFAOYSA-N 0.000 description 2
- PSXGJOOHDPCVMB-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(4-methylcyclohexen-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CCC(CC1)C)SC(C)C)C PSXGJOOHDPCVMB-UHFFFAOYSA-N 0.000 description 2
- DWCDBJXJFRDDGK-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(4-methylpiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)C)SC(C)C)C DWCDBJXJFRDDGK-UHFFFAOYSA-N 0.000 description 2
- DHWNEVSOEHIBKO-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C=1OC(=NN=1)C)SC(C)C)C DHWNEVSOEHIBKO-UHFFFAOYSA-N 0.000 description 2
- LVOHTWJMSFETDK-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-(2-methylprop-1-enyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C(C)C)C LVOHTWJMSFETDK-UHFFFAOYSA-N 0.000 description 2
- MONMQFMKVVUITN-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-(2-methylpropyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CC(C)C)C MONMQFMKVVUITN-UHFFFAOYSA-N 0.000 description 2
- FXTNMWFVZPMLIY-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-[3-(methylamino)-3-oxopropyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CCC(=O)NC)C FXTNMWFVZPMLIY-UHFFFAOYSA-N 0.000 description 2
- KVDGLCNQBDTZEO-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=NN=1)C1=CC=C(C=C1)C(F)(F)F)C KVDGLCNQBDTZEO-UHFFFAOYSA-N 0.000 description 2
- JPWBXESEDHCIAY-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-[4-(trifluoromethyl)phenyl]-4-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F)C JPWBXESEDHCIAY-UHFFFAOYSA-N 0.000 description 2
- LDSVVHIOWFIJNE-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)cyclohexen-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CCC(CC1)C(F)(F)F)SC(C)C)C LDSVVHIOWFIJNE-UHFFFAOYSA-N 0.000 description 2
- WNJBPYQHSXQXDW-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)C(F)(F)F)SC(C)C)C WNJBPYQHSXQXDW-UHFFFAOYSA-N 0.000 description 2
- BIFUPFDVXPCIJM-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-oxo-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-1H-pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)O BIFUPFDVXPCIJM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- RDRQUUWCJTYHCT-UHFFFAOYSA-N 4-(trifluoromethyl)piperidine Chemical compound FC(F)(F)C1CCNCC1 RDRQUUWCJTYHCT-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- ZZPPLNHMEQXAFZ-UHFFFAOYSA-N 4-bromo-2-chloro-5-propan-2-ylsulfanyl-1,3-thiazole Chemical compound BrC=1N=C(SC=1SC(C)C)Cl ZZPPLNHMEQXAFZ-UHFFFAOYSA-N 0.000 description 2
- MZZXIXHKDJNBJQ-UHFFFAOYSA-N 4-iodo-3,5-dimethyl-1h-pyrazole Chemical compound CC1=NNC(C)=C1I MZZXIXHKDJNBJQ-UHFFFAOYSA-N 0.000 description 2
- IKOYAQXGLSFYSH-UHFFFAOYSA-N 5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(N)=NN=C1C1=CC=C(C(F)(F)F)C=C1 IKOYAQXGLSFYSH-UHFFFAOYSA-N 0.000 description 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000283724 Bison bonasus Species 0.000 description 2
- 206010005949 Bone cancer Diseases 0.000 description 2
- 208000018084 Bone neoplasm Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 229940126074 CDK kinase inhibitor Drugs 0.000 description 2
- AZPUSFJDSCCFLL-UHFFFAOYSA-N CON=C(C(=O)OC)C(C(C)=O)CC1=C(C=CC=C1)[N+](=O)[O-] Chemical compound CON=C(C(=O)OC)C(C(C)=O)CC1=C(C=CC=C1)[N+](=O)[O-] AZPUSFJDSCCFLL-UHFFFAOYSA-N 0.000 description 2
- 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102000016736 Cyclin Human genes 0.000 description 2
- 108050006400 Cyclin Proteins 0.000 description 2
- 102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- 206010014967 Ependymoma Diseases 0.000 description 2
- 206010018338 Glioma Diseases 0.000 description 2
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010021042 Hypopharyngeal cancer Diseases 0.000 description 2
- 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 2
- 208000009164 Islet Cell Adenoma Diseases 0.000 description 2
- 206010062038 Lip neoplasm Diseases 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 101150111584 RHOA gene Proteins 0.000 description 2
- 239000012979 RPMI medium Substances 0.000 description 2
- 201000000582 Retinoblastoma Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 2
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 2
- GYIZAXTVOCGVGF-UHFFFAOYSA-N [5-(3,4-dichlorophenyl)-1H-1,2,4-triazol-3-yl]hydrazine Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1)NN GYIZAXTVOCGVGF-UHFFFAOYSA-N 0.000 description 2
- AJAWLDJBMAQJPJ-UHFFFAOYSA-N [5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]hydrazine Chemical compound S1C(NN)=NN=C1C1=CC=C(C(F)(F)F)C=C1 AJAWLDJBMAQJPJ-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 125000003725 azepanyl group Chemical group 0.000 description 2
- 125000002393 azetidinyl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004600 benzothiopyranyl group Chemical group S1C(C=CC2=C1C=CC=C2)* 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 208000030224 brain astrocytoma Diseases 0.000 description 2
- 229940045348 brown mixture Drugs 0.000 description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000005907 cancer growth Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 201000007335 cerebellar astrocytoma Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 208000006990 cholangiocarcinoma Diseases 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000018514 detection of nutrient Effects 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- KTXYICVCBKJUNA-UHFFFAOYSA-N dimethyl 2,5-dioxohex-3-ynedioate Chemical compound O=C(C(=O)OC)C#CC(C(=O)OC)=O KTXYICVCBKJUNA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 239000012055 enteric layer Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 208000003884 gestational trophoblastic disease Diseases 0.000 description 2
- 230000006377 glucose transport Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 201000010536 head and neck cancer Diseases 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 2
- 201000006866 hypopharynx cancer Diseases 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 2
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 201000006721 lip cancer Diseases 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- SSBBBMAGUNTNBR-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1)N1N=C(C=C1C(=O)OC)C SSBBBMAGUNTNBR-UHFFFAOYSA-N 0.000 description 2
- BEJDACOZALRRDD-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-5-fluoro-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1F)N1N=C(C=C1C(=O)OC)C BEJDACOZALRRDD-UHFFFAOYSA-N 0.000 description 2
- HDPKKXAARPNSDE-UHFFFAOYSA-N methyl 2-[4-(4-acetylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-bromo-5-methylpyrazole-3-carboxylate Chemical compound C(C)(=O)N1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)OC)Br)C HDPKKXAARPNSDE-UHFFFAOYSA-N 0.000 description 2
- CXMHXQPOLLYCDN-UHFFFAOYSA-N methyl 2-[4-[4-chloro-2-(oxetan-3-yloxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound ClC1=CC(=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)OC)C)OC1COC1 CXMHXQPOLLYCDN-UHFFFAOYSA-N 0.000 description 2
- GMCDRFGRXMTOPE-UHFFFAOYSA-N methyl 2-[4-[4-chloro-3-(oxetan-3-yloxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)OC)C)OC1COC1 GMCDRFGRXMTOPE-UHFFFAOYSA-N 0.000 description 2
- LOKNCTCPGAZHOU-UHFFFAOYSA-N methyl 2-[5-ethenyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C)C LOKNCTCPGAZHOU-UHFFFAOYSA-N 0.000 description 2
- PUXXHXMYSJGJRW-UHFFFAOYSA-N methyl 2-[5-iodo-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound IC1=C(N=C(S1)N1N=C(C=C1C(=O)OC)C)C1=CC=C(C=C1)C(F)(F)F PUXXHXMYSJGJRW-UHFFFAOYSA-N 0.000 description 2
- PJVFWRWEINDOKY-UHFFFAOYSA-N methyl 2-methoxyimino-4-oxopentanoate Chemical compound CON=C(CC(C)=O)C(=O)OC PJVFWRWEINDOKY-UHFFFAOYSA-N 0.000 description 2
- ZRXPLUYQNSLBSB-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[4-(2-methylprop-1-enyl)-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C=C(C)C)C1=CC=C(C=C1)C(F)(F)F)C ZRXPLUYQNSLBSB-UHFFFAOYSA-N 0.000 description 2
- OKOJVEQTGFNVAO-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[4-(4-methylcyclohexen-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CCC(CC1)C)SC(C)C)C OKOJVEQTGFNVAO-UHFFFAOYSA-N 0.000 description 2
- WZXVKCJYFVZDCT-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[4-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C=1OC(=NN=1)C)SC(C)C)C WZXVKCJYFVZDCT-UHFFFAOYSA-N 0.000 description 2
- GQXIXMKIUSLAIB-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[5-(2-methylprop-1-enyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C(C)C)C GQXIXMKIUSLAIB-UHFFFAOYSA-N 0.000 description 2
- JBCGOVLRTBXHBN-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[5-[3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C)(C)(C)OC(C=CC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)C1=CC(=CC=C1)F)C)C1=CC=C(C=C1)C(F)(F)F)=O JBCGOVLRTBXHBN-UHFFFAOYSA-N 0.000 description 2
- DKEBRAGJARVYPR-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-methyl-2-[5-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C)(C)(C)OC(CCC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)C1=CC(=CC=C1)F)C)C1=CC=C(C=C1)C(F)(F)F)=O DKEBRAGJARVYPR-UHFFFAOYSA-N 0.000 description 2
- ZFQKHBZKVBKJLQ-UHFFFAOYSA-N methyl 4-(3-fluorophenyl)-5-oxo-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-1H-pyrazole-3-carboxylate Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)O ZFQKHBZKVBKJLQ-UHFFFAOYSA-N 0.000 description 2
- VRXPCMLXOYURSD-UHFFFAOYSA-N methyl 4-bromo-2-(4,5-dibromo-1,3-thiazol-2-yl)-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)Br)Br)C VRXPCMLXOYURSD-UHFFFAOYSA-N 0.000 description 2
- HIJVALCWDXAILR-UHFFFAOYSA-N methyl 4-bromo-2-[4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CCC2(OCCO2)CC1)SC(C)C)C HIJVALCWDXAILR-UHFFFAOYSA-N 0.000 description 2
- ZNYHQSIJGHUBSU-UHFFFAOYSA-N methyl 4-bromo-2-[4-(3,4-dichlorophenyl)-5-fluoro-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)F)C ZNYHQSIJGHUBSU-UHFFFAOYSA-N 0.000 description 2
- ILVRRIRLMZKBIT-UHFFFAOYSA-N methyl 4-bromo-2-[4-(4-cyanopiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCC(CC1)C#N)SC(C)C)C ILVRRIRLMZKBIT-UHFFFAOYSA-N 0.000 description 2
- SCWMYYVSNAFBAH-UHFFFAOYSA-N methyl 4-bromo-2-[4-(4-cyclopropylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCN(CC1)C1CC1)SC(C)C)C SCWMYYVSNAFBAH-UHFFFAOYSA-N 0.000 description 2
- IOZMVKHQDXRFQV-UHFFFAOYSA-N methyl 4-bromo-2-[4-(4-ethylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCN(CC1)CC)SC(C)C)C IOZMVKHQDXRFQV-UHFFFAOYSA-N 0.000 description 2
- TYCOZVIWDQFADB-UHFFFAOYSA-N methyl 4-bromo-2-[4-[4-chloro-3-(morpholine-4-carbonyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)C(=O)N1CCOCC1)SC(C)C)C TYCOZVIWDQFADB-UHFFFAOYSA-N 0.000 description 2
- JXNMKNIWRFNTOX-UHFFFAOYSA-N methyl 4-bromo-2-[5-ethenyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C)C JXNMKNIWRFNTOX-UHFFFAOYSA-N 0.000 description 2
- GIWGELKZUXJLPW-UHFFFAOYSA-N methyl 4-bromo-5-methoxy-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)OC GIWGELKZUXJLPW-UHFFFAOYSA-N 0.000 description 2
- NIFMYSKKKXTTIY-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-(4-morpholin-4-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCOCC1)SC(C)C)C NIFMYSKKKXTTIY-UHFFFAOYSA-N 0.000 description 2
- AZXHIPDKUNDUNW-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-(4-piperidin-1-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCCCC1)SC(C)C)C AZXHIPDKUNDUNW-UHFFFAOYSA-N 0.000 description 2
- RTIWFDLTXPEFPP-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[4-(2-methylprop-1-enyl)-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C=C(C)C)C1=CC=C(C=C1)C(F)(F)F)C RTIWFDLTXPEFPP-UHFFFAOYSA-N 0.000 description 2
- YWTQYOUJYWCRNL-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[4-(4-methylcyclohexen-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CCC(CC1)C)SC(C)C)C YWTQYOUJYWCRNL-UHFFFAOYSA-N 0.000 description 2
- LAEIVLQDHCPJJK-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[4-(4-methylpiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCC(CC1)C)SC(C)C)C LAEIVLQDHCPJJK-UHFFFAOYSA-N 0.000 description 2
- RHVUZFUEXICSRV-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[4-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C=1OC(=NN=1)C)SC(C)C)C RHVUZFUEXICSRV-UHFFFAOYSA-N 0.000 description 2
- XKUSZFZJOPQRFN-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[5-(2-methylpropyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CC(C)C)C XKUSZFZJOPQRFN-UHFFFAOYSA-N 0.000 description 2
- CWSSZBHIEGJHDU-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=NN=1)C1=CC=C(C=C1)C(F)(F)F)C CWSSZBHIEGJHDU-UHFFFAOYSA-N 0.000 description 2
- UCGHFPSJJAEOHR-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[5-[4-(trifluoromethyl)phenyl]-4-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCC(CC1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F)C UCGHFPSJJAEOHR-UHFFFAOYSA-N 0.000 description 2
- LDFMMTSQFOBWCJ-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)cyclohexen-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CCC(CC1)C(F)(F)F)SC(C)C)C LDFMMTSQFOBWCJ-UHFFFAOYSA-N 0.000 description 2
- YMMKPGPRFSDFJH-UHFFFAOYSA-N methyl 4-bromo-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)N1CCC(CC1)C(F)(F)F)SC(C)C)C YMMKPGPRFSDFJH-UHFFFAOYSA-N 0.000 description 2
- AGCOOTRPINMNNJ-UHFFFAOYSA-N methyl 4-bromo-5-oxo-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-1H-pyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)O AGCOOTRPINMNNJ-UHFFFAOYSA-N 0.000 description 2
- MTCJRBNMHOFGOU-UHFFFAOYSA-N methyl 4-iodo-5-methyl-2-[5-(2-methylprop-1-enyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound IC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C(C)C)C MTCJRBNMHOFGOU-UHFFFAOYSA-N 0.000 description 2
- QLRYNWYULVWMJN-UHFFFAOYSA-N methyl 4-iodo-5-methyl-2-[5-[3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C)(C)(C)OC(C=CC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)I)C)C1=CC=C(C=C1)C(F)(F)F)=O QLRYNWYULVWMJN-UHFFFAOYSA-N 0.000 description 2
- LKDAIHSMPLZCDW-UHFFFAOYSA-N methyl 5-acetyloxy-4-bromo-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C)(=O)OC1=NN(C(=C1Br)C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C LKDAIHSMPLZCDW-UHFFFAOYSA-N 0.000 description 2
- SRGCCTKUCZZWLT-UHFFFAOYSA-N methyl 5-methoxy-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C)(C)SC1=C(N=C(S1)N1N=C(C=C1C(=O)OC)OC)C1=CC=C(C=C1)C(F)(F)F SRGCCTKUCZZWLT-UHFFFAOYSA-N 0.000 description 2
- CPSNMNHOQFKMKW-UHFFFAOYSA-N methyl 5-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound CC1=NN(C(=C1)C(=O)OC)C=1SC=C(N=1)C1=CC=C(C=C1)C(F)(F)F CPSNMNHOQFKMKW-UHFFFAOYSA-N 0.000 description 2
- LXFDTMZIKBSCEK-UHFFFAOYSA-N methyl 5-methyl-2-[5-(2-methylprop-1-enyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound CC1=NN(C(=C1)C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C=C(C)C LXFDTMZIKBSCEK-UHFFFAOYSA-N 0.000 description 2
- PXLHBRGRAJXETK-UHFFFAOYSA-N methyl 5-methyl-2-[5-(2-methylpropyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylate Chemical compound C(C(C)C)C1=C(N=C(S1)N1N=C(C=C1C(=O)OC)C)C1=CC=C(C=C1)C(F)(F)F PXLHBRGRAJXETK-UHFFFAOYSA-N 0.000 description 2
- GBHVYXSTYOOSBU-UHFFFAOYSA-N methyl 5-methyl-2-[5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]pyrazole-3-carboxylate Chemical compound CC1=NN(C(=C1)C(=O)OC)C=1SC(=NN=1)C1=CC=C(C=C1)C(F)(F)F GBHVYXSTYOOSBU-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- QMLWSAXEQSBAAQ-UHFFFAOYSA-N oxetan-3-ol Chemical compound OC1COC1 QMLWSAXEQSBAAQ-UHFFFAOYSA-N 0.000 description 2
- 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 2
- 208000021010 pancreatic neuroendocrine tumor Diseases 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000005494 pyridonyl group Chemical group 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 108700042226 ras Genes Proteins 0.000 description 2
- 230000022983 regulation of cell cycle Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 201000002314 small intestine cancer Diseases 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 108700026239 src Genes Proteins 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
- 229910052722 tritium Inorganic materials 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- KYCNFLXMOJWIKM-UHFFFAOYSA-N (3-aminoazetidin-1-yl)-[4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazol-3-yl]methanone Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(=O)N1CC(N)C1)-c1cc(cc(c1)C(F)(F)F)C(F)(F)F KYCNFLXMOJWIKM-UHFFFAOYSA-N 0.000 description 1
- ZNEOOHPDJLKJEE-UHFFFAOYSA-N (3-fluorophenoxy)boronic acid Chemical compound OB(O)OC1=CC=CC(F)=C1 ZNEOOHPDJLKJEE-UHFFFAOYSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- UJPMYEOUBPIPHQ-UHFFFAOYSA-N 1,1,1-trifluoroethane Chemical compound CC(F)(F)F UJPMYEOUBPIPHQ-UHFFFAOYSA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- HNZJIWIXRPBFAN-UHFFFAOYSA-N 1-cyclopropylpiperazine Chemical compound C1CC1N1CCNCC1 HNZJIWIXRPBFAN-UHFFFAOYSA-N 0.000 description 1
- MNZAKDODWSQONA-UHFFFAOYSA-N 1-dibutylphosphorylbutane Chemical compound CCCCP(=O)(CCCC)CCCC MNZAKDODWSQONA-UHFFFAOYSA-N 0.000 description 1
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- IDCPFAYURAQKDZ-UHFFFAOYSA-N 1-nitroguanidine Chemical compound NC(=N)N[N+]([O-])=O IDCPFAYURAQKDZ-UHFFFAOYSA-N 0.000 description 1
- PKDPUENCROCRCH-UHFFFAOYSA-N 1-piperazin-1-ylethanone Chemical compound CC(=O)N1CCNCC1 PKDPUENCROCRCH-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical group C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- IEUQLXVHBHEVSJ-UHFFFAOYSA-N 2-(1h-pyrrol-2-yloxy)-1h-pyrrole Chemical compound C=1C=CNC=1OC1=CC=CN1 IEUQLXVHBHEVSJ-UHFFFAOYSA-N 0.000 description 1
- GRARQDVUZIBPSK-UHFFFAOYSA-N 2-(4-benzyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1Cc1ccccc1)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 GRARQDVUZIBPSK-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- HEMIXKBRKYHBND-UHFFFAOYSA-N 2-[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound COC1=CC=C(C=C1)C=1N=C(SC=1C1=CC=C(C=C1)OC)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C HEMIXKBRKYHBND-UHFFFAOYSA-N 0.000 description 1
- KLXJYYCBHROYPO-UHFFFAOYSA-N 2-[4,5-bis[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound FC(C1=CC=C(C=C1)C=1N=C(SC=1C1=CC=C(C=C1)C(F)(F)F)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)(F)F KLXJYYCBHROYPO-UHFFFAOYSA-N 0.000 description 1
- NOAUQEDTMWBIPH-UHFFFAOYSA-N 2-[4-(1,5-dimethyl-6-oxopyridin-3-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CN1C=C(C=C(C1=O)C)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C NOAUQEDTMWBIPH-UHFFFAOYSA-N 0.000 description 1
- ROWKJAIHSSRAAB-UHFFFAOYSA-N 2-[4-(1-benzofuran-2-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound O1C(=CC2=C1C=CC=C2)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C ROWKJAIHSSRAAB-UHFFFAOYSA-N 0.000 description 1
- JCZKTMVPOKESLJ-UHFFFAOYSA-N 2-[4-(1-benzofuran-3-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound O1C=C(C2=C1C=CC=C2)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C JCZKTMVPOKESLJ-UHFFFAOYSA-N 0.000 description 1
- SMVNDYKPVGNTMG-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=CC(=C1)Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C SMVNDYKPVGNTMG-UHFFFAOYSA-N 0.000 description 1
- XIGCXLSBFVRWDE-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=CC(=C1)Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C XIGCXLSBFVRWDE-UHFFFAOYSA-N 0.000 description 1
- UWWPBPYFPFUZNU-UHFFFAOYSA-N 2-[4-(2,5-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cc(Cl)ccc1Cl)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 UWWPBPYFPFUZNU-UHFFFAOYSA-N 0.000 description 1
- DAGKNEHTYSRRKR-UHFFFAOYSA-N 2-[4-(2,5-dimethylpyrazol-3-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cc(C)nn1C)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 DAGKNEHTYSRRKR-UHFFFAOYSA-N 0.000 description 1
- JBEKYUBGXZLICQ-UHFFFAOYSA-N 2-[4-(2,6-dimethylpyridin-4-yl)-3,5-dimethylpyrazol-1-yl]-5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C)-c1cc(C)nc(C)c1 JBEKYUBGXZLICQ-UHFFFAOYSA-N 0.000 description 1
- UUAJPPARMBFYKL-UHFFFAOYSA-N 2-[4-(2-chlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=CC=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C UUAJPPARMBFYKL-UHFFFAOYSA-N 0.000 description 1
- YPLVPCMOJJJSTQ-UHFFFAOYSA-N 2-[4-(2-cyanophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C1=C(C=CC=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C YPLVPCMOJJJSTQ-UHFFFAOYSA-N 0.000 description 1
- JIZGTFFFQGGRHP-UHFFFAOYSA-N 2-[4-(2-cyclopropylethynyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1C#CC1CC1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 JIZGTFFFQGGRHP-UHFFFAOYSA-N 0.000 description 1
- KUDPBVSUEQSCBL-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C KUDPBVSUEQSCBL-UHFFFAOYSA-N 0.000 description 1
- CBNYCWOEWOSDBK-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-5-methyl-4-(1-methylpyrazol-4-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1CC(C)C)N1N=C(C(=C1C(=O)O)C=1C=NN(C=1)C)C CBNYCWOEWOSDBK-UHFFFAOYSA-N 0.000 description 1
- FALPMYLYEHFHCI-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-(3-methylbutylsulfanyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SCCC(C)C)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C FALPMYLYEHFHCI-UHFFFAOYSA-N 0.000 description 1
- GVXNCVCHVDIPLL-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-ethylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SCC)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C GVXNCVCHVDIPLL-UHFFFAOYSA-N 0.000 description 1
- PEXDFOCCNCOBRU-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-methylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound CSc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(Cc2ccccc2[N+]([O-])=O)c1C(O)=O PEXDFOCCNCOBRU-UHFFFAOYSA-N 0.000 description 1
- QLZDTLQLJMOVLI-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-yloxy-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1OC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C QLZDTLQLJMOVLI-UHFFFAOYSA-N 0.000 description 1
- PBRDGBTWDZRCOW-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1,5-dimethyl-6-oxopyridin-3-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CN(C(C(=C1)C)=O)C)C PBRDGBTWDZRCOW-UHFFFAOYSA-N 0.000 description 1
- SMWZZSCNDZZXQM-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1H-imidazol-2-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2ncc[nH]2)c1C(O)=O SMWZZSCNDZZXQM-UHFFFAOYSA-N 0.000 description 1
- YSLVJDDDJUQQGD-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1H-indol-3-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2c[nH]c3ccccc23)c1C(O)=O YSLVJDDDJUQQGD-UHFFFAOYSA-N 0.000 description 1
- ZYEBESUKWSHESQ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1H-indol-6-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccc2cc[nH]c2c1 ZYEBESUKWSHESQ-UHFFFAOYSA-N 0.000 description 1
- IMGNRWQYNVJIDK-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1H-indol-7-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=CC=C2C=CNC=12)C IMGNRWQYNVJIDK-UHFFFAOYSA-N 0.000 description 1
- ZJHVRFRZPWXUSP-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-ethoxypyridin-3-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C(=NC=CC=1)OCC)C ZJHVRFRZPWXUSP-UHFFFAOYSA-N 0.000 description 1
- OKVHIASOHQGVLL-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-fluoropyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccnc(F)c1 OKVHIASOHQGVLL-UHFFFAOYSA-N 0.000 description 1
- IUQPURIMGKNDDY-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-methoxy-5-methylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound COc1ccc(C)cc1-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O IUQPURIMGKNDDY-UHFFFAOYSA-N 0.000 description 1
- KUWLKOPHYVOZFA-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-methoxy-6-methylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)OC)C KUWLKOPHYVOZFA-UHFFFAOYSA-N 0.000 description 1
- RAUHSDFGZIRUAC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-methoxyphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound COc1ccccc1-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O RAUHSDFGZIRUAC-UHFFFAOYSA-N 0.000 description 1
- BOXGSELGBAFMAK-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2-methoxypyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound COc1cc(ccn1)-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O BOXGSELGBAFMAK-UHFFFAOYSA-N 0.000 description 1
- QZFYRPYHSUVUET-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3,5-difluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)F)F)C QZFYRPYHSUVUET-UHFFFAOYSA-N 0.000 description 1
- BSEVELVVEZCQES-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3,5-dimethyl-1,2-oxazol-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2c(C)noc2C)c1C(O)=O BSEVELVVEZCQES-UHFFFAOYSA-N 0.000 description 1
- FRQQCYFOYWIVFT-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3,5-dimethylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)C)C FRQQCYFOYWIVFT-UHFFFAOYSA-N 0.000 description 1
- KHYKGZXPXYLAFL-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluoro-5-hydroxyphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)O)F)C KHYKGZXPXYLAFL-UHFFFAOYSA-N 0.000 description 1
- HEOPVJMANAIOLC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluoro-5-methoxyphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)OC)F)C HEOPVJMANAIOLC-UHFFFAOYSA-N 0.000 description 1
- JMSSKKSXILTFLK-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluoro-5-methylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)F)C JMSSKKSXILTFLK-UHFFFAOYSA-N 0.000 description 1
- GHVGRKSEXVZNGF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C GHVGRKSEXVZNGF-UHFFFAOYSA-N 0.000 description 1
- UWTBIFKQUHBOEJ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-propan-2-ylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C(C)C UWTBIFKQUHBOEJ-UHFFFAOYSA-N 0.000 description 1
- WWCTVUJERAYOQC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-hydroxy-5-methylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)O)C WWCTVUJERAYOQC-UHFFFAOYSA-N 0.000 description 1
- SLXGLIYUQYJCNL-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-imidazol-1-yl-5-methylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound N1(C=NC=C1)C=1C=C(C=C(C=1)C)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C SLXGLIYUQYJCNL-UHFFFAOYSA-N 0.000 description 1
- CKORRDOCFKEBTI-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-methoxy-5-methylphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)OC)C CKORRDOCFKEBTI-UHFFFAOYSA-N 0.000 description 1
- HJDIKUMLROUTKZ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-methoxyphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)OC)C HJDIKUMLROUTKZ-UHFFFAOYSA-N 0.000 description 1
- VCEIHLJHLFKSBZ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=NC(=CC(=N1)C)C)C VCEIHLJHLFKSBZ-UHFFFAOYSA-N 0.000 description 1
- UZRUYXNBGCPHKM-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(4-methoxyphenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound COc1ccc(cc1)-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O UZRUYXNBGCPHKM-UHFFFAOYSA-N 0.000 description 1
- HYNNHZKBBVGYED-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(4-methoxypyrimidin-2-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=NC=CC(=N1)OC)C HYNNHZKBBVGYED-UHFFFAOYSA-N 0.000 description 1
- NOLUBXJNJJXNEA-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(5-methoxypyridin-3-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=NC=C(C=1)OC)C NOLUBXJNJJXNEA-UHFFFAOYSA-N 0.000 description 1
- FUCFDUUESODUTF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[1-(dimethylcarbamoyl)pyrazol-4-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2cnn(c2)C(=O)N(C)C)c1C(O)=O FUCFDUUESODUTF-UHFFFAOYSA-N 0.000 description 1
- CRQNIAVUIHMPOW-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[2-(2-methoxyethoxy)-6-methylpyridin-4-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)OCCOC)C CRQNIAVUIHMPOW-UHFFFAOYSA-N 0.000 description 1
- ZUXHJDXGIOUGGZ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-(dimethylamino)-5-methylphenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)N(C)C)C ZUXHJDXGIOUGGZ-UHFFFAOYSA-N 0.000 description 1
- WZMRXKKRAKRMLX-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-(hydroxymethyl)-5-methyl-1,2-oxazol-4-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2c(C)onc2CO)c1C(O)=O WZMRXKKRAKRMLX-UHFFFAOYSA-N 0.000 description 1
- KQUGRTGWCAZPHE-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-(hydroxymethyl)phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cccc(CO)c1 KQUGRTGWCAZPHE-UHFFFAOYSA-N 0.000 description 1
- FXYLOVCJVYAFFU-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound COCc1noc(C)c1-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O FXYLOVCJVYAFFU-UHFFFAOYSA-N 0.000 description 1
- WLWCAAXRVDQGJH-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-(methoxymethyl)phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)COC)C WLWCAAXRVDQGJH-UHFFFAOYSA-N 0.000 description 1
- LPCCCTKLINIWAJ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-[(dimethylamino)methyl]phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cccc(CN(C)C)c1 LPCCCTKLINIWAJ-UHFFFAOYSA-N 0.000 description 1
- NKBKGZJISGHNPB-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-fluoro-5-(oxetan-3-yloxy)phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)OC1COC1)F)C NKBKGZJISGHNPB-UHFFFAOYSA-N 0.000 description 1
- UZNQVSSGSASJAF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[3-methoxy-5-(trifluoromethyl)phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C(F)(F)F)OC)C UZNQVSSGSASJAF-UHFFFAOYSA-N 0.000 description 1
- CIFOXLJQSLUULJ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[4-(hydroxymethyl)phenyl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccc(CO)cc1 CIFOXLJQSLUULJ-UHFFFAOYSA-N 0.000 description 1
- GSKKJMCYXJFCIM-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-[hydroxy(phenyl)methyl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C(C1=CC=CC=C1)O)C GSKKJMCYXJFCIM-UHFFFAOYSA-N 0.000 description 1
- TXYJFSSQZMISLF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-imidazo[1,2-a]pyridin-3-yl-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CN=C2N1C=CC=C2)C TXYJFSSQZMISLF-UHFFFAOYSA-N 0.000 description 1
- XSMQLSUSNQTVDI-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-imidazo[1,2-a]pyridin-6-yl-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=CC=2N(C=1)C=CN=2)C XSMQLSUSNQTVDI-UHFFFAOYSA-N 0.000 description 1
- XSQZPLDAGRTMDC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(1,2-thiazol-4-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=NSC=1)C XSQZPLDAGRTMDC-UHFFFAOYSA-N 0.000 description 1
- BCLIUOTVGBQKPC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(1-methyl-2-oxopyridin-4-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(N(C=C1)C)=O)C BCLIUOTVGBQKPC-UHFFFAOYSA-N 0.000 description 1
- BWZUQNHFWBSMAB-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(1-methylindol-7-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=CC=C2C=CN(C=12)C)C BWZUQNHFWBSMAB-UHFFFAOYSA-N 0.000 description 1
- DDRZSAYZFVOIHA-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(1-methylpyrazol-4-yl)pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2cnn(C)c2)c1C(O)=O DDRZSAYZFVOIHA-UHFFFAOYSA-N 0.000 description 1
- TXUUSLFWGCBLFM-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(2-methyl-6-morpholin-4-ylpyridin-4-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)N1CCOCC1)C)C TXUUSLFWGCBLFM-UHFFFAOYSA-N 0.000 description 1
- OOANXQQUPKQTTJ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(2-methylphenyl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=C(C=CC=C1)C)C OOANXQQUPKQTTJ-UHFFFAOYSA-N 0.000 description 1
- FAOQQBHJTOANOY-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(2-methylpyridin-4-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC=C1)C)C FAOQQBHJTOANOY-UHFFFAOYSA-N 0.000 description 1
- LYQKAZZHUBBREW-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(3-methyl-1,2-thiazol-5-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NS1)C)C LYQKAZZHUBBREW-UHFFFAOYSA-N 0.000 description 1
- HXIAHOSYXKRDKO-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(3-methyl-5-propan-2-yloxyphenyl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)C)OC(C)C)C HXIAHOSYXKRDKO-UHFFFAOYSA-N 0.000 description 1
- NMGNNTDQDGNCMF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(3-methylphenyl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=C(C=CC=1)C)C NMGNNTDQDGNCMF-UHFFFAOYSA-N 0.000 description 1
- YADNNXVQXLFPNK-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(3-nitrophenyl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)[N+](=O)[O-])C YADNNXVQXLFPNK-UHFFFAOYSA-N 0.000 description 1
- DVYCFNZMSKHLDX-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(3-propan-2-ylphenyl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)C(C)C)C DVYCFNZMSKHLDX-UHFFFAOYSA-N 0.000 description 1
- HUDGHKUNUOHSFB-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(4-methylphenyl)pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccc(C)cc1 HUDGHKUNUOHSFB-UHFFFAOYSA-N 0.000 description 1
- XMDBLGXZZHYRKC-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(5-methyl-1,3,4-thiadiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1SC(=NN=1)C)C XMDBLGXZZHYRKC-UHFFFAOYSA-N 0.000 description 1
- BNVZTDSUULFFHN-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-([1,2,4]triazolo[4,3-a]pyridin-3-yl)pyrazole-3-carboxylic acid Chemical compound N=1N=C(N2C=1C=CC=C2)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C BNVZTDSUULFFHN-UHFFFAOYSA-N 0.000 description 1
- RHBGHYKYOAJEJN-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C RHBGHYKYOAJEJN-UHFFFAOYSA-N 0.000 description 1
- CMRNNUOMLDOYLV-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[2-(methylamino)pyridin-4-yl]pyrazole-3-carboxylic acid Chemical compound CNc1cc(ccn1)-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(Cl)c(Cl)c2)c1C(O)=O CMRNNUOMLDOYLV-UHFFFAOYSA-N 0.000 description 1
- NDRHKZQYOCRMNO-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[2-(trifluoromethyl)phenyl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccccc1C(F)(F)F NDRHKZQYOCRMNO-UHFFFAOYSA-N 0.000 description 1
- VEMPMFUYQOPCSU-GOSISDBHSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[2-methyl-6-[(3R)-oxolan-3-yl]oxypyridin-4-yl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)O[C@H]1COCC1)C)C VEMPMFUYQOPCSU-GOSISDBHSA-N 0.000 description 1
- VEMPMFUYQOPCSU-SFHVURJKSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[2-methyl-6-[(3S)-oxolan-3-yl]oxypyridin-4-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(O[C@H]2CCOC2)c1 VEMPMFUYQOPCSU-SFHVURJKSA-N 0.000 description 1
- CZYWMFFLRQDAET-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[3-(trifluoromethyl)phenyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)C(F)(F)F)C CZYWMFFLRQDAET-UHFFFAOYSA-N 0.000 description 1
- WOYNMHCUEOKFQF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[4-(trifluoromethyl)phenyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC=C(C=C1)C(F)(F)F)C WOYNMHCUEOKFQF-UHFFFAOYSA-N 0.000 description 1
- DKEAWIWYEVCZRI-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-phenylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC=CC=C1)C DKEAWIWYEVCZRI-UHFFFAOYSA-N 0.000 description 1
- GLHVEXREDGAVAX-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyrazin-2-ylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=NC=CN=C1)C GLHVEXREDGAVAX-UHFFFAOYSA-N 0.000 description 1
- ZEIRLEKXRFQDNH-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyrazolo[1,5-a]pyridin-3-ylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(-c2cnn3ccccc23)c1C(O)=O ZEIRLEKXRFQDNH-UHFFFAOYSA-N 0.000 description 1
- PSSOCDAUKBVBCU-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyrazolo[1,5-a]pyrimidin-3-ylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=NN2C=1N=CC=C2)C PSSOCDAUKBVBCU-UHFFFAOYSA-N 0.000 description 1
- IGBQLNJDAUKXHU-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyridin-3-ylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cccnc1 IGBQLNJDAUKXHU-UHFFFAOYSA-N 0.000 description 1
- YOTBRZLOECNIQH-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyridin-4-ylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC=NC=C1)C YOTBRZLOECNIQH-UHFFFAOYSA-N 0.000 description 1
- IRMDSVOXTWCHSR-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-pyrimidin-5-ylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C=1C=NC=NC=1)C IRMDSVOXTWCHSR-UHFFFAOYSA-N 0.000 description 1
- MAUOUQYHEUAZQW-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C=C1C(=O)O)C MAUOUQYHEUAZQW-UHFFFAOYSA-N 0.000 description 1
- DTODNZCFHDWJHA-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-N-(2-methoxyethyl)-5-methyl-4-(3-methylphenyl)pyrazole-3-carboxamide Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)NCCOC)C=1C=C(C=CC=1)C)C DTODNZCFHDWJHA-UHFFFAOYSA-N 0.000 description 1
- YODGRPVMOPXDHQ-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfinyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound CC(C)S(=O)c1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(Cc2ccccc2[N+]([O-])=O)c1C(O)=O YODGRPVMOPXDHQ-UHFFFAOYSA-N 0.000 description 1
- POOUHXZBHFGCJP-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfonyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound CC(C)S(=O)(=O)c1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(Cc2ccccc2[N+]([O-])=O)c1C(O)=O POOUHXZBHFGCJP-UHFFFAOYSA-N 0.000 description 1
- XVLCXMOLINJRPR-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-5-propylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SCCC)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C XVLCXMOLINJRPR-UHFFFAOYSA-N 0.000 description 1
- CJPBBCPHXNTNRY-UHFFFAOYSA-N 2-[4-(3-chloro-4-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1C)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C CJPBBCPHXNTNRY-UHFFFAOYSA-N 0.000 description 1
- QEBDTYQMHBKWFD-UHFFFAOYSA-N 2-[4-(3-chlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C QEBDTYQMHBKWFD-UHFFFAOYSA-N 0.000 description 1
- SMFOVGUUZLFUAR-UHFFFAOYSA-N 2-[4-(3-chlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C SMFOVGUUZLFUAR-UHFFFAOYSA-N 0.000 description 1
- UPTHXPRMQXSQOZ-UHFFFAOYSA-N 2-[4-(3-fluoro-4-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(C)c(F)c1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 UPTHXPRMQXSQOZ-UHFFFAOYSA-N 0.000 description 1
- ARJRMFMVIMXNAJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)-3-methylpyrazol-1-yl]-4,5-bis[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F)C ARJRMFMVIMXNAJ-UHFFFAOYSA-N 0.000 description 1
- BDQKDQHAWYXBPH-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(1H-indol-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cccc(F)c1)-n1nc(C)c(c1C(O)=O)-c1cccc2[nH]ccc12 BDQKDQHAWYXBPH-UHFFFAOYSA-N 0.000 description 1
- ZJLFIFZKZXJTIW-UHFFFAOYSA-N 2-[4-(3-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound C(C)(C)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C)C1=CC(=CC=C1)OC ZJLFIFZKZXJTIW-UHFFFAOYSA-N 0.000 description 1
- LDLCABFBODCIAY-UHFFFAOYSA-N 2-[4-(4-chloro-2,6-dimethylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=CC(=C(C(=C1)C)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C LDLCABFBODCIAY-UHFFFAOYSA-N 0.000 description 1
- UAIBGLFUKRZFOL-UHFFFAOYSA-N 2-[4-(4-chloro-2-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=CC(=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)OC UAIBGLFUKRZFOL-UHFFFAOYSA-N 0.000 description 1
- APERRSOLTNTBAT-UHFFFAOYSA-N 2-[4-(4-chloro-2-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound COc1cc(Cl)ccc1-c1nc(sc1SC(C)C)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 APERRSOLTNTBAT-UHFFFAOYSA-N 0.000 description 1
- ZZRFJOXPLSEOKX-UHFFFAOYSA-N 2-[4-(4-chloro-2-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)cc1C)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 ZZRFJOXPLSEOKX-UHFFFAOYSA-N 0.000 description 1
- VVOBMFBSUFCBTG-UHFFFAOYSA-N 2-[4-(4-chloro-3,5-difluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1F)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)F VVOBMFBSUFCBTG-UHFFFAOYSA-N 0.000 description 1
- ORSQSKGGBCEGMI-UHFFFAOYSA-N 2-[4-(4-chloro-3,5-difluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1F)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)F ORSQSKGGBCEGMI-UHFFFAOYSA-N 0.000 description 1
- HFIQXKIONITWLB-UHFFFAOYSA-N 2-[4-(4-chloro-3-cyanophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C#N HFIQXKIONITWLB-UHFFFAOYSA-N 0.000 description 1
- CPPCVBKYOCIASF-UHFFFAOYSA-N 2-[4-(4-chloro-3-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)OC CPPCVBKYOCIASF-UHFFFAOYSA-N 0.000 description 1
- VCRMCFNBVQTSME-UHFFFAOYSA-N 2-[4-(4-chloro-3-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)OC VCRMCFNBVQTSME-UHFFFAOYSA-N 0.000 description 1
- SDKJDOIQFOZQQE-UHFFFAOYSA-N 2-[4-(4-chloro-3-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)C SDKJDOIQFOZQQE-UHFFFAOYSA-N 0.000 description 1
- SRXLJVVLZGIGPV-UHFFFAOYSA-N 2-[4-(4-chloro-3-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C SRXLJVVLZGIGPV-UHFFFAOYSA-N 0.000 description 1
- IAOXDIRRAYYABX-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=CC=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C IAOXDIRRAYYABX-UHFFFAOYSA-N 0.000 description 1
- PTKVAGYCDFWYNI-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=CC=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C PTKVAGYCDFWYNI-UHFFFAOYSA-N 0.000 description 1
- YSMZHPPXKHMYMV-UHFFFAOYSA-N 2-[4-(4-cyano-3-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(C#N)c(C)c1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 YSMZHPPXKHMYMV-UHFFFAOYSA-N 0.000 description 1
- KDSZWLSDLLFKBY-UHFFFAOYSA-N 2-[4-(4-cyanophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C1=CC=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C KDSZWLSDLLFKBY-UHFFFAOYSA-N 0.000 description 1
- GSIPKLJPLASQCB-UHFFFAOYSA-N 2-[4-(4-ethylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)C1=CC=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C GSIPKLJPLASQCB-UHFFFAOYSA-N 0.000 description 1
- QKQVPPXAHQNESG-UHFFFAOYSA-N 2-[4-(4-fluoro-3-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound FC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)OC QKQVPPXAHQNESG-UHFFFAOYSA-N 0.000 description 1
- MBIXOWVGXJGNGS-UHFFFAOYSA-N 2-[4-(4-tert-butyl-3-oxopiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)(C)(C)N1C(CN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)=O MBIXOWVGXJGNGS-UHFFFAOYSA-N 0.000 description 1
- NCNGBIQBLGBFMB-UHFFFAOYSA-N 2-[4-(4-tert-butylpiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)(C)(C)C1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C NCNGBIQBLGBFMB-UHFFFAOYSA-N 0.000 description 1
- ZFNWONWIYDABIQ-UHFFFAOYSA-N 2-[4-(5-chloro-2-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=CC(=C(C=1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)F ZFNWONWIYDABIQ-UHFFFAOYSA-N 0.000 description 1
- ZLXXVGPIBXWJKU-UHFFFAOYSA-N 2-[4-(5-chloro-2-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3,5-dichlorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=CC(=C(C=1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)Cl)Cl)C)F ZLXXVGPIBXWJKU-UHFFFAOYSA-N 0.000 description 1
- GJKXXTLZLMMUDN-UHFFFAOYSA-N 2-[4-(5-cyanopyridin-3-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cncc(c1)C#N)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 GJKXXTLZLMMUDN-UHFFFAOYSA-N 0.000 description 1
- WIKUALXMWADVNC-UHFFFAOYSA-N 2-[4-(6-azaspiro[2.5]octan-6-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC2(CC2)CC1)SC(C)C)C WIKUALXMWADVNC-UHFFFAOYSA-N 0.000 description 1
- JWPWCLVSIQTBHN-UHFFFAOYSA-N 2-[4-(cyclohexen-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C1(=CCCCC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C JWPWCLVSIQTBHN-UHFFFAOYSA-N 0.000 description 1
- CGKZQEYUQHBUJS-UHFFFAOYSA-N 2-[4-(cyclopenten-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C1(=CCCC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C CGKZQEYUQHBUJS-UHFFFAOYSA-N 0.000 description 1
- PMYHLBILMVFUPH-UHFFFAOYSA-N 2-[4-[2-amino-4-(trifluoromethyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound NC1=C(C=CC(=C1)C(F)(F)F)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C PMYHLBILMVFUPH-UHFFFAOYSA-N 0.000 description 1
- QLIJYPLNVMJMFJ-UHFFFAOYSA-N 2-[4-[2-chloro-5-(trifluoromethoxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cc(OC(F)(F)F)ccc1Cl)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 QLIJYPLNVMJMFJ-UHFFFAOYSA-N 0.000 description 1
- ZSZPDRBEGJCYEF-UHFFFAOYSA-N 2-[4-[4-(1,1-difluoroethyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(C)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 ZSZPDRBEGJCYEF-UHFFFAOYSA-N 0.000 description 1
- JOIKSTXYOXVAMT-UHFFFAOYSA-N 2-[4-[4-(difluoromethyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 JOIKSTXYOXVAMT-UHFFFAOYSA-N 0.000 description 1
- WPDNASVPISYKQN-UHFFFAOYSA-N 2-[4-[4-(dimethylcarbamoyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound CN(C(=O)C1=CC=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C WPDNASVPISYKQN-UHFFFAOYSA-N 0.000 description 1
- ICVPLYYMPUXQQH-UHFFFAOYSA-N 2-[4-[4-chloro-3-(ethylcarbamoyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC1=C(C=C(C=C1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C(NCC)=O ICVPLYYMPUXQQH-UHFFFAOYSA-N 0.000 description 1
- ILOOJEWVWVLTQT-UHFFFAOYSA-N 2-[5-[4-[2-(2-ethoxyethoxy)ethoxy]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-4-(3-fluorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)OCCOCCOC1=CC=C(C=C1)C1=C(N=C(S1)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C)C1=CC=C(C=C1)C(F)(F)F ILOOJEWVWVLTQT-UHFFFAOYSA-N 0.000 description 1
- JQSPKELXHMTKCP-UHFFFAOYSA-N 2-[5-butan-2-ylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)(CC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)O)C1=CC(=NC(=C1)C)C)C)C1=CC(=C(C=C1)Cl)Cl JQSPKELXHMTKCP-UHFFFAOYSA-N 0.000 description 1
- VUCMGZNEECFOJJ-UHFFFAOYSA-N 2-[5-butan-2-ylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-4-(3,5-dichlorophenyl)-5-methylpyrazole-3-carboxylic acid Chemical compound C(C)(CC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)O)C1=CC(=CC(=C1)Cl)Cl)C)C1=CC(=C(C=C1)Cl)Cl VUCMGZNEECFOJJ-UHFFFAOYSA-N 0.000 description 1
- DWVDCAJIUVSLMU-UHFFFAOYSA-N 2-[5-butan-2-ylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound CCC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(Cc2ccccc2[N+]([O-])=O)c1C(O)=O DWVDCAJIUVSLMU-UHFFFAOYSA-N 0.000 description 1
- DQQSQMRGWBLSSH-UHFFFAOYSA-N 2-[5-butylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound C(CCC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C)C1=CC(=C(C=C1)Cl)Cl DQQSQMRGWBLSSH-UHFFFAOYSA-N 0.000 description 1
- HJYNYTUUXSZFHD-UHFFFAOYSA-N 2-[5-cyclohexylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylic acid Chemical compound C1(CCCCC1)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)O)CC1=C(C=CC=C1)[N+](=O)[O-])C)C1=CC(=C(C=C1)Cl)Cl HJYNYTUUXSZFHD-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 1
- FMRKYXVZQWHGDA-UHFFFAOYSA-N 2-bromo-5-chlorophenol Chemical compound OC1=CC(Cl)=CC=C1Br FMRKYXVZQWHGDA-UHFFFAOYSA-N 0.000 description 1
- KLEYVGWAORGTIT-UHFFFAOYSA-N 2-chlorothiazole Chemical compound ClC1=NC=CS1 KLEYVGWAORGTIT-UHFFFAOYSA-N 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- WDGCBNTXZHJTHJ-UHFFFAOYSA-N 2h-1,3-oxazol-2-id-4-one Chemical compound O=C1CO[C-]=N1 WDGCBNTXZHJTHJ-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- SDXAWLJRERMRKF-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazole Chemical compound CC=1C=C(C)NN=1 SDXAWLJRERMRKF-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- MJOUJKDTBGXKIU-UHFFFAOYSA-N 4,4-difluoropiperidine Chemical compound FC1(F)CCNCC1 MJOUJKDTBGXKIU-UHFFFAOYSA-N 0.000 description 1
- DZTHEKLICLBHOS-UHFFFAOYSA-N 4-(1-benzofuran-2-yl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound O1C(=CC2=C1C=CC=C2)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C DZTHEKLICLBHOS-UHFFFAOYSA-N 0.000 description 1
- MAJFXOYKTPWSQG-UHFFFAOYSA-N 4-(1h-pyrazol-5-yl)-2h-triazole Chemical compound N1C=CC(C=2N=NNC=2)=N1 MAJFXOYKTPWSQG-UHFFFAOYSA-N 0.000 description 1
- QLLYRQZOCSEFIF-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-2-[4-(2-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound COc1ccccc1-c1nc(sc1SC(C)C)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 QLLYRQZOCSEFIF-UHFFFAOYSA-N 0.000 description 1
- GGQMECZUGFSNLO-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-2-[4-(3-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC1=NC(=CC(=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=CC=C1)OC)SC(C)C)C)C GGQMECZUGFSNLO-UHFFFAOYSA-N 0.000 description 1
- UVMDQXFLRAXSHM-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-2-[4-(4-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(F)cc1)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 UVMDQXFLRAXSHM-UHFFFAOYSA-N 0.000 description 1
- AFQXRNDMIMXCPC-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-2-[4-(4-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound COc1ccc(cc1)-c1nc(sc1SC(C)C)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 AFQXRNDMIMXCPC-UHFFFAOYSA-N 0.000 description 1
- JDHFXUABCVDJAQ-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-(4-phenyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound CC1=NC(=CC(=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=CC=C1)SC(C)C)C)C JDHFXUABCVDJAQ-UHFFFAOYSA-N 0.000 description 1
- LQHPVOVCRXWRIZ-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-[4-(2-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccccc1C)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 LQHPVOVCRXWRIZ-UHFFFAOYSA-N 0.000 description 1
- MOKJTKYOFMWHRV-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-[4-(3-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC1=NC(=CC(=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=C(C=CC=1)C)SC(C)C)C)C MOKJTKYOFMWHRV-UHFFFAOYSA-N 0.000 description 1
- KUNBHHGAFAIHBJ-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-[4-(4-methylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(C)cc1)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(C)c1 KUNBHHGAFAIHBJ-UHFFFAOYSA-N 0.000 description 1
- LJRJNGCNARWYBW-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-4-yl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC1=NC(=CC(=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C)C LJRJNGCNARWYBW-UHFFFAOYSA-N 0.000 description 1
- AENDHTKVUZVCGR-UHFFFAOYSA-N 4-(2-chlorophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccccc1Cl AENDHTKVUZVCGR-UHFFFAOYSA-N 0.000 description 1
- FSOYSGLRUGDQDG-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-[4-(1H-indol-7-yl)-3-methylpyrazol-1-yl]-5-propan-2-ylsulfanyl-1,3-thiazole Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1cc(c(C)n1)-c1cccc2cc[nH]c12 FSOYSGLRUGDQDG-UHFFFAOYSA-N 0.000 description 1
- VBGNUHKNSSJROF-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-[4-(2,6-dimethylpyridin-4-yl)-3-methylpyrazol-1-yl]-5-propan-2-ylsulfanyl-1,3-thiazole Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1)C1=CC(=NC(=C1)C)C)C VBGNUHKNSSJROF-UHFFFAOYSA-N 0.000 description 1
- FPFPTPFXSLWTSJ-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-2-pyrazol-1-yl-1,3-thiazole Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=CC=C1 FPFPTPFXSLWTSJ-UHFFFAOYSA-N 0.000 description 1
- WCFJEFYTTOAEAO-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1ccc(F)c(F)c1 WCFJEFYTTOAEAO-UHFFFAOYSA-N 0.000 description 1
- SZDQTUYZIHKQNG-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-2-(4-imidazo[1,2-a]pyridin-6-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=CC=2N(C=1)C=CN=2)SC(C)C)C SZDQTUYZIHKQNG-UHFFFAOYSA-N 0.000 description 1
- YHBFECVIZKHLOV-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C YHBFECVIZKHLOV-UHFFFAOYSA-N 0.000 description 1
- AKRHBYATBBQGSH-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-2-[4-(3,5-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=CC(=C1)Cl)Cl)SC(C)C)C AKRHBYATBBQGSH-UHFFFAOYSA-N 0.000 description 1
- DIXZHIXNBFQRDR-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-2-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C(=NOC=1C)C)SC(C)C)C DIXZHIXNBFQRDR-UHFFFAOYSA-N 0.000 description 1
- RZMTURMKQKQTPV-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-5-methyl-2-(5-propan-2-ylsulfanyl-4-pyridin-3-yl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC=CC=1)SC(C)C)C RZMTURMKQKQTPV-UHFFFAOYSA-N 0.000 description 1
- IZCLSWLUQVPKDB-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-5-methyl-2-(5-propan-2-ylsulfanyl-4-pyridin-4-yl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=NC=C1)SC(C)C)C IZCLSWLUQVPKDB-UHFFFAOYSA-N 0.000 description 1
- CMESLHPIQDIEGL-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-5-methyl-2-[4-(1-methylpyrazol-4-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NN(C=1)C)SC(C)C)C CMESLHPIQDIEGL-UHFFFAOYSA-N 0.000 description 1
- HGZJTAWHZNZYKL-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C HGZJTAWHZNZYKL-UHFFFAOYSA-N 0.000 description 1
- ZSOGAVVEDTUOLM-UHFFFAOYSA-N 4-(3-amino-5-methylphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound NC=1C=C(C=C(C=1)C)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C ZSOGAVVEDTUOLM-UHFFFAOYSA-N 0.000 description 1
- CECDCHBVADXEHN-UHFFFAOYSA-N 4-(3-benzyl-5-methyl-1,2-oxazol-4-yl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C(C1=CC=CC=C1)C1=NOC(=C1C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)C CECDCHBVADXEHN-UHFFFAOYSA-N 0.000 description 1
- ZXYDGNNHJKHMSN-UHFFFAOYSA-N 4-(3-chloro-2-methylphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C(=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)C ZXYDGNNHJKHMSN-UHFFFAOYSA-N 0.000 description 1
- UVEWCMUGFFKEGI-UHFFFAOYSA-N 4-(3-chloro-5-fluorophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)F)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C UVEWCMUGFFKEGI-UHFFFAOYSA-N 0.000 description 1
- PHDDVGFWCAHBLI-UHFFFAOYSA-N 4-(3-chloro-5-hydroxyphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)O)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C PHDDVGFWCAHBLI-UHFFFAOYSA-N 0.000 description 1
- HZCSNNDPVJENCU-UHFFFAOYSA-N 4-(3-chloro-5-methoxyphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)OC)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C HZCSNNDPVJENCU-UHFFFAOYSA-N 0.000 description 1
- ZZHGJRLMSHTOID-UHFFFAOYSA-N 4-(3-chloro-5-methoxyphenyl)-5-methyl-2-(4-phenyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)OC)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=CC=C1)SC(C)C)C ZZHGJRLMSHTOID-UHFFFAOYSA-N 0.000 description 1
- AGZCDYPFUZKGRO-UHFFFAOYSA-N 4-(3-chloro-5-methoxyphenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)OC)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C AGZCDYPFUZKGRO-UHFFFAOYSA-N 0.000 description 1
- HWCGIOBYFXKCLR-UHFFFAOYSA-N 4-(3-chloro-5-methylphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)C)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C HWCGIOBYFXKCLR-UHFFFAOYSA-N 0.000 description 1
- DDHXDZIUPLUIJN-UHFFFAOYSA-N 4-(3-chloro-5-propan-2-yloxyphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)OC(C)C)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C DDHXDZIUPLUIJN-UHFFFAOYSA-N 0.000 description 1
- VHQGALFAMVLQLA-UHFFFAOYSA-N 4-(3-chlorophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C VHQGALFAMVLQLA-UHFFFAOYSA-N 0.000 description 1
- XTXXRIMNXMIIEE-UHFFFAOYSA-N 4-(3-cyano-5-methoxyphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C=1C=C(C=C(C=1)OC)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C XTXXRIMNXMIIEE-UHFFFAOYSA-N 0.000 description 1
- YXBTXYDDJZMSJF-UHFFFAOYSA-N 4-(3-cyano-5-methylphenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C=1C=C(C=C(C=1)C)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C YXBTXYDDJZMSJF-UHFFFAOYSA-N 0.000 description 1
- UPZRZIIECZAVRZ-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(1H-indol-4-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cccc2[nH]ccc12)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 UPZRZIIECZAVRZ-UHFFFAOYSA-N 0.000 description 1
- HAMQWCAPAPVSHF-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(1H-indol-5-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc2[nH]ccc2c1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 HAMQWCAPAPVSHF-UHFFFAOYSA-N 0.000 description 1
- FGVVCPHMRVSKQO-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(3-fluorophenyl)-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=CC=C1)F)C1=CC=C(C=C1)C(F)(F)F)C FGVVCPHMRVSKQO-UHFFFAOYSA-N 0.000 description 1
- PTQKNXFCSPKCSJ-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(3-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=CC=C1)F)SC(C)C)C PTQKNXFCSPKCSJ-UHFFFAOYSA-N 0.000 description 1
- GEBIACHNTAMPIG-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(4-fluorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)F)SC(C)C)C GEBIACHNTAMPIG-UHFFFAOYSA-N 0.000 description 1
- ZBVZNYYQZRSPRM-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(4-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)OC)C1=CC=C(C=C1)C(F)(F)F)C ZBVZNYYQZRSPRM-UHFFFAOYSA-N 0.000 description 1
- LJDBULUBFCYDIC-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(4-methoxyphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)OC)SC(C)C)C LJDBULUBFCYDIC-UHFFFAOYSA-N 0.000 description 1
- WPGKCFWTBCKSBL-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-(5-fluoropyridin-3-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC=C(C=1)F)SC(C)C)C WPGKCFWTBCKSBL-UHFFFAOYSA-N 0.000 description 1
- FAVQFPULQZOYNO-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-[4-(2-methoxyethoxy)-4-(trifluoromethyl)piperidin-1-yl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)(C(F)(F)F)OCCOC)SC(C)C)C FAVQFPULQZOYNO-UHFFFAOYSA-N 0.000 description 1
- BKERHSQEIPQBPR-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-[4-(2-methoxyethylcarbamoyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(NCCOC)=O)SC(C)C)C BKERHSQEIPQBPR-UHFFFAOYSA-N 0.000 description 1
- AWPZZTBRRNIBJH-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[4-[4-methoxy-4-(trifluoromethyl)piperidin-1-yl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)(C(F)(F)F)OC)SC(C)C)C AWPZZTBRRNIBJH-UHFFFAOYSA-N 0.000 description 1
- MOJWDINGMVNHPX-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(1-hydroxyethyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C(C)O)C MOJWDINGMVNHPX-UHFFFAOYSA-N 0.000 description 1
- IRFGSCOKPCDOAM-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(1-methoxyethyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C(C)OC)C IRFGSCOKPCDOAM-UHFFFAOYSA-N 0.000 description 1
- YDRDXVSBBVJBHG-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(3-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC(=CC=C1)F)C YDRDXVSBBVJBHG-UHFFFAOYSA-N 0.000 description 1
- CYRQULRVUOCILV-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(4-methoxyphenyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)OC)C CYRQULRVUOCILV-UHFFFAOYSA-N 0.000 description 1
- YPLCMRXNEOKHGI-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(hydroxymethyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CO)C YPLCMRXNEOKHGI-UHFFFAOYSA-N 0.000 description 1
- PYXQFFSDMQRZKG-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-(methoxymethyl)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)COC)C PYXQFFSDMQRZKG-UHFFFAOYSA-N 0.000 description 1
- GBARCWRQYBYIQH-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[3-(2-methoxyethylamino)-3-oxopropyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CCC(=O)NCCOC)C GBARCWRQYBYIQH-UHFFFAOYSA-N 0.000 description 1
- MNIOJZUXIPAEPG-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[3-[2-methoxyethyl(methyl)amino]-3-oxopropyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)CCC(=O)N(C)CCOC)C MNIOJZUXIPAEPG-UHFFFAOYSA-N 0.000 description 1
- ZKDVPTRNSAKTNV-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-(2-methoxyethoxy)phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)OCCOC)C ZKDVPTRNSAKTNV-UHFFFAOYSA-N 0.000 description 1
- VSFQPUPWARSYMC-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-(2-methoxyethylcarbamoyl)phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)C(NCCOC)=O)C VSFQPUPWARSYMC-UHFFFAOYSA-N 0.000 description 1
- ZAOLQUZTLMMBIX-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-[(2-methoxyacetyl)-methylamino]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)N(C(COC)=O)C)C ZAOLQUZTLMMBIX-UHFFFAOYSA-N 0.000 description 1
- GCIORPXAHQQNCT-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-[(2-methoxyacetyl)amino]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)NC(COC)=O)C GCIORPXAHQQNCT-UHFFFAOYSA-N 0.000 description 1
- HDFPPXRPFDGKMA-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-[2-methoxyethyl(methyl)carbamoyl]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)C(N(C)CCOC)=O)C HDFPPXRPFDGKMA-UHFFFAOYSA-N 0.000 description 1
- XWDVJXSJJDSZJE-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-[[2-(2-methoxyethoxy)acetyl]-methylamino]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)N(C(COCCOC)=O)C)C XWDVJXSJJDSZJE-UHFFFAOYSA-N 0.000 description 1
- PKEAENJRMIHJDF-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-[4-[[2-(2-methoxyethoxy)acetyl]amino]phenyl]-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)C1=CC=C(C=C1)NC(COCCOC)=O)C PKEAENJRMIHJDF-UHFFFAOYSA-N 0.000 description 1
- WSPDDIHABUXUIM-UHFFFAOYSA-N 4-(3-fluorophenyl)-2-[5-fluoro-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound Cc1nn(-c2nc(c(F)s2)-c2ccc(cc2)C(F)(F)F)c(C(O)=O)c1-c1cccc(F)c1 WSPDDIHABUXUIM-UHFFFAOYSA-N 0.000 description 1
- ZQPHEIORKWOJDL-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-(4-phenyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccccc1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 ZQPHEIORKWOJDL-UHFFFAOYSA-N 0.000 description 1
- VSEJDOCSAASISS-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-(4-piperazin-1-yl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCNCC1)SC(C)C)C VSEJDOCSAASISS-UHFFFAOYSA-N 0.000 description 1
- JJWDZEXJXQTQMU-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-(5-propan-2-ylsulfanyl-4-pyrimidin-5-yl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC=NC=1)SC(C)C)C JJWDZEXJXQTQMU-UHFFFAOYSA-N 0.000 description 1
- AMWBBRHGFYJMIU-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(4-methylpiperazin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1N1CCN(C)CC1)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 AMWBBRHGFYJMIU-UHFFFAOYSA-N 0.000 description 1
- OTDNZOBVLFHQIT-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(4-methylsulfonylphenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)S(=O)(=O)C)SC(C)C)C OTDNZOBVLFHQIT-UHFFFAOYSA-N 0.000 description 1
- MEXZXVXRHYRETJ-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-(4-propan-2-ylpiperidin-1-yl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CCC(CC1)C(C)C)SC(C)C)C MEXZXVXRHYRETJ-UHFFFAOYSA-N 0.000 description 1
- BMXYRXJERBXSLF-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[2-methyl-4-(trifluoromethoxy)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=C(C=C(C=C1)OC(F)(F)F)C)SC(C)C)C BMXYRXJERBXSLF-UHFFFAOYSA-N 0.000 description 1
- MDMHLVQMOMDXDC-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[2-methyl-4-(trifluoromethyl)phenyl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1C)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 MDMHLVQMOMDXDC-UHFFFAOYSA-N 0.000 description 1
- MZHXONXWLYFZHN-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[4-(trifluoromethyl)cyclohexyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC=C(N=1)C1CCC(CC1)C(F)(F)F)C MZHXONXWLYFZHN-UHFFFAOYSA-N 0.000 description 1
- RGZSPIGFWIPTBA-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound Cc1nn(-c2nc(cs2)-c2ccc(cc2)C(F)(F)F)c(C(O)=O)c1-c1cccc(F)c1 RGZSPIGFWIPTBA-UHFFFAOYSA-N 0.000 description 1
- AFXZTDNOAFVTCB-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[4-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound C(C)(C)(C)OC(=O)N1CCN(CC1)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)O)C1=CC(=CC=C1)F)C AFXZTDNOAFVTCB-UHFFFAOYSA-N 0.000 description 1
- XGDBUGMDSRKBNQ-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-(propan-2-ylamino)-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Nc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 XGDBUGMDSRKBNQ-UHFFFAOYSA-N 0.000 description 1
- YVGHAXQJAUYQMP-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[2-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccccc1C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 YVGHAXQJAUYQMP-UHFFFAOYSA-N 0.000 description 1
- CZDYAUBEINGBFB-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[2-(trifluoromethyl)pyrimidin-5-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC(=NC=1)C(F)(F)F)SC(C)C)C CZDYAUBEINGBFB-UHFFFAOYSA-N 0.000 description 1
- IQWLUTBGTQWWRQ-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[2-[4-(trifluoromethyl)phenyl]ethynyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1C#Cc1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 IQWLUTBGTQWWRQ-UHFFFAOYSA-N 0.000 description 1
- QRYIRPDCNYIDNR-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1cccc(c1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cccc(F)c1 QRYIRPDCNYIDNR-UHFFFAOYSA-N 0.000 description 1
- UFKOWJPTINPQAR-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[3-(trifluoromethyl)pyrrolidin-1-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)N1CC(CC1)C(F)(F)F)SC(C)C)C UFKOWJPTINPQAR-UHFFFAOYSA-N 0.000 description 1
- GSNFPWJBJXXVOS-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)OC(F)(F)F)SC(C)C)C GSNFPWJBJXXVOS-UHFFFAOYSA-N 0.000 description 1
- SUCBTCNLOGPBJT-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-N-propylsulfonylpyrazole-3-carboxamide Chemical compound CCCS(=O)(=O)NC(=O)c1c(c(C)nn1-c1nc(c(SC(C)C)s1)-c1ccc(cc1)C(F)(F)F)-c1cccc(F)c1 SUCBTCNLOGPBJT-UHFFFAOYSA-N 0.000 description 1
- CSKLESTWCMVVHO-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C CSKLESTWCMVVHO-UHFFFAOYSA-N 0.000 description 1
- UMHGEDUTBGXZAN-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[5-(trifluoromethyl)pyrimidin-2-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=NC=C(C=N1)C(F)(F)F)SC(C)C)C UMHGEDUTBGXZAN-UHFFFAOYSA-N 0.000 description 1
- PDLSEKVRFZWELZ-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[6-(trifluoromethyl)pyridin-3-yl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC(=CC=1)C(F)(F)F)SC(C)C)C PDLSEKVRFZWELZ-UHFFFAOYSA-N 0.000 description 1
- IYLDRJUEJLXASM-UHFFFAOYSA-N 4-(3-fluorophenyl)-N-(2-methoxyethyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxamide Chemical compound COCCNC(=O)c1c(c(C)nn1-c1nc(c(SC(C)C)s1)-c1ccc(cc1)C(F)(F)F)-c1cccc(F)c1 IYLDRJUEJLXASM-UHFFFAOYSA-N 0.000 description 1
- IYNHFFAOCNUHNF-UHFFFAOYSA-N 4-(3-fluorophenyl)-N-(2-methoxyethyl)-N,5-dimethyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxamide Chemical compound COCCN(C)C(=O)c1c(c(C)nn1-c1nc(c(SC(C)C)s1)-c1ccc(cc1)C(F)(F)F)-c1cccc(F)c1 IYNHFFAOCNUHNF-UHFFFAOYSA-N 0.000 description 1
- ARAPAQQMVXGSCE-UHFFFAOYSA-N 4-(3-fluorophenyl)-N-methoxy-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxamide Chemical compound FC=1C=C(C=CC=1)C=1C(=NN(C=1C(=O)NOC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C ARAPAQQMVXGSCE-UHFFFAOYSA-N 0.000 description 1
- FWUDFVACFNSXDA-UHFFFAOYSA-N 4-(4-acetamidophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccc(NC(C)=O)cc1 FWUDFVACFNSXDA-UHFFFAOYSA-N 0.000 description 1
- NPPJLFZNGOBJHY-UHFFFAOYSA-N 4-(4-aminophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound NC1=CC=C(C=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C NPPJLFZNGOBJHY-UHFFFAOYSA-N 0.000 description 1
- LTQHZDWRLACDRH-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1ccc(Cl)cc1 LTQHZDWRLACDRH-UHFFFAOYSA-N 0.000 description 1
- CQQNXQACOPFDDK-UHFFFAOYSA-N 4-(4-fluoro-3,5-dimethylphenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1cc(C)c(F)c(C)c1 CQQNXQACOPFDDK-UHFFFAOYSA-N 0.000 description 1
- COHDOOWSZNXKMR-UHFFFAOYSA-N 4-(4-fluoro-3-methoxyphenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound COc1cc(ccc1F)-c1c(C)nn(-c2nc(c(SC(C)C)s2)-c2ccc(cc2)C(F)(F)F)c1C(O)=O COHDOOWSZNXKMR-UHFFFAOYSA-N 0.000 description 1
- HQPGIDYZTWGHPO-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound FC1=C(C=C(C=C1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)SC(C)C)C)C HQPGIDYZTWGHPO-UHFFFAOYSA-N 0.000 description 1
- PFUVUIKPNUDZPW-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-methyl-2-[5-propan-2-ylsulfanyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(cc1)C(F)(F)F)-n1nc(C)c(c1C(O)=O)-c1ccc(F)cc1 PFUVUIKPNUDZPW-UHFFFAOYSA-N 0.000 description 1
- IUYGEMYNGXWGNW-UHFFFAOYSA-N 4-(5-cyanopyridin-3-yl)-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C=1C=C(C=NC=1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C IUYGEMYNGXWGNW-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- WWNUVUUICLZWNY-UHFFFAOYSA-N 4-[2-(azetidin-1-yl)-6-methylpyridin-4-yl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cc(C)nc(c1)N1CCC1 WWNUVUUICLZWNY-UHFFFAOYSA-N 0.000 description 1
- RLFLJMOPFCNOFI-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-N-(2H-tetrazol-5-yl)pyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)NC1=NN=NN1)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F RLFLJMOPFCNOFI-UHFFFAOYSA-N 0.000 description 1
- SEFUATXBIDIHIG-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-N-(pyridin-2-ylmethyl)pyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)NCC1=NC=CC=C1)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F SEFUATXBIDIHIG-UHFFFAOYSA-N 0.000 description 1
- HMFLZQRJNRRHSW-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-N-methylsulfonylpyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)NS(=O)(=O)C)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F HMFLZQRJNRRHSW-UHFFFAOYSA-N 0.000 description 1
- YPOPOSCHIMBRSP-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F YPOPOSCHIMBRSP-UHFFFAOYSA-N 0.000 description 1
- SPXQGJRTQRWZCG-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F SPXQGJRTQRWZCG-UHFFFAOYSA-N 0.000 description 1
- KXFSCKORYBNZFI-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-N,5-dimethyl-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]pyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N(C=1SC(=NN=1)C(F)(F)F)C)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F KXFSCKORYBNZFI-UHFFFAOYSA-N 0.000 description 1
- NWGAOOYLLAKCQP-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-N-(2-hydroxyethyl)-N,5-dimethylpyrazole-3-carboxamide Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N(C)CCO)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F NWGAOOYLLAKCQP-UHFFFAOYSA-N 0.000 description 1
- CZNHTBFQFSUNLX-UHFFFAOYSA-N 4-[3-(aminomethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccc(Cl)c(Cl)c1)-n1nc(C)c(c1C(O)=O)-c1cccc(CN)c1 CZNHTBFQFSUNLX-UHFFFAOYSA-N 0.000 description 1
- KZSMQEYSHVBZKW-UHFFFAOYSA-N 4-[3-chloro-5-(2-methoxyethoxy)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound ClC=1C=C(C=C(C=1)OCCOC)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C KZSMQEYSHVBZKW-UHFFFAOYSA-N 0.000 description 1
- QDERFYINTAKVBB-UHFFFAOYSA-N 4-[3-cyano-5-(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C(#N)C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C QDERFYINTAKVBB-UHFFFAOYSA-N 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- GAZFZFLWBTZRAI-UHFFFAOYSA-N 4-bromo-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound BrC=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C GAZFZFLWBTZRAI-UHFFFAOYSA-N 0.000 description 1
- SPMBLJBMVQRLIB-UHFFFAOYSA-N 4-bromo-2-[4-[6-(3-fluorophenyl)pyridin-3-yl]-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound BrC=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C=1C=NC(=CC=1)C1=CC(=CC=C1)F)SC(C)C)C SPMBLJBMVQRLIB-UHFFFAOYSA-N 0.000 description 1
- DJAKCEWDBXVTNT-UHFFFAOYSA-N 4-cyclopropyl-2-(4-cyclopropyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)-5-methylpyrazole-3-carboxylic acid Chemical compound C1(CC1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1CC1)SC(C)C)C DJAKCEWDBXVTNT-UHFFFAOYSA-N 0.000 description 1
- OTLUKUCHFQGALL-UHFFFAOYSA-N 4-cyclopropyl-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylic acid Chemical compound C1(CC1)C=1C(=NN(C=1C(=O)O)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C OTLUKUCHFQGALL-UHFFFAOYSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- SWKPKONEIZGROQ-UHFFFAOYSA-N 4-trifluoromethylbenzoic acid Chemical compound OC(=O)C1=CC=C(C(F)(F)F)C=C1 SWKPKONEIZGROQ-UHFFFAOYSA-N 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- UEVFFMZHGNYDKM-UHFFFAOYSA-N 5-bromo-2-chlorophenol Chemical compound OC1=CC(Br)=CC=C1Cl UEVFFMZHGNYDKM-UHFFFAOYSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- CDEURGJCGCHYFH-DJLDLDEBSA-N 5-ethynyl-2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C#C)=C1 CDEURGJCGCHYFH-DJLDLDEBSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- ZTAMWGNUFWHFAG-UHFFFAOYSA-N 5-methyl-4-(1-methylpyrazol-4-yl)-2-(4-phenyl-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl)pyrazole-3-carboxylic acid Chemical compound CC(C)Sc1sc(nc1-c1ccccc1)-n1nc(C)c(-c2cnn(C)c2)c1C(O)=O ZTAMWGNUFWHFAG-UHFFFAOYSA-N 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000002008 AIDS-Related Lymphoma Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004956 Amodel Substances 0.000 description 1
- 206010061424 Anal cancer Diseases 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010060971 Astrocytoma malignant Diseases 0.000 description 1
- 201000008271 Atypical teratoid rhabdoid tumor Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006143 Brain stem glioma Diseases 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- 108091007914 CDKs Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
- 206010007953 Central nervous system lymphoma Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 229940127007 Compound 39 Drugs 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 101150086683 DYRK1A gene Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000017259 Extragonadal germ cell tumor Diseases 0.000 description 1
- 201000001342 Fallopian tube cancer Diseases 0.000 description 1
- 208000013452 Fallopian tube neoplasm Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 230000010337 G2 phase Effects 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 102000058063 Glucose Transporter Type 1 Human genes 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061252 Intraocular melanoma Diseases 0.000 description 1
- 206010069755 K-ras gene mutation Diseases 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010069698 Langerhans' cell histiocytosis Diseases 0.000 description 1
- 208000004059 Male Breast Neoplasms Diseases 0.000 description 1
- 208000032271 Malignant tumor of penis Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033833 Myelomonocytic Chronic Leukemia Diseases 0.000 description 1
- QLDAMYPDANIFDH-UHFFFAOYSA-N N-(2-aminoethyl)-4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-N,5-dimethylpyrazole-3-carboxamide Chemical compound NCCN(C(=O)C1=C(C(=NN1C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C QLDAMYPDANIFDH-UHFFFAOYSA-N 0.000 description 1
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 1
- SGPNKGRVDKDLTP-UHFFFAOYSA-N N-[2-[[5-[4-(aminomethyl)piperidine-1-carbonyl]-1-[4-(3,4-dichlorophenyl)-5-propylsulfanyl-1,3-thiazol-2-yl]-3-methylpyrazol-4-yl]methyl]phenyl]methanesulfonamide Chemical compound NCC1CCN(CC1)C(=O)C1=C(C(=NN1C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SCCC)C)CC1=C(C=CC=C1)NS(=O)(=O)C SGPNKGRVDKDLTP-UHFFFAOYSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- 206010028767 Nasal sinus cancer Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000000160 Olfactory Esthesioneuroblastoma Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 206010061332 Paraganglion neoplasm Diseases 0.000 description 1
- 208000003937 Paranasal Sinus Neoplasms Diseases 0.000 description 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000002471 Penile Neoplasms Diseases 0.000 description 1
- 206010034299 Penile cancer Diseases 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 206010034811 Pharyngeal cancer Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 208000026149 Primary peritoneal carcinoma Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 241000720974 Protium Species 0.000 description 1
- 201000008183 Pulmonary blastoma Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 108091006296 SLC2A1 Proteins 0.000 description 1
- 206010061934 Salivary gland cancer Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 206010043515 Throat cancer Diseases 0.000 description 1
- 208000000728 Thymus Neoplasms Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 208000006593 Urologic Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 201000005969 Uveal melanoma Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
- 230000006682 Warburg effect Effects 0.000 description 1
- 208000008383 Wilms tumor Diseases 0.000 description 1
- 241001660687 Xantho Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- QODYBSUBPQGRIG-UHFFFAOYSA-N [4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazine Chemical compound S1C(NN)=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 QODYBSUBPQGRIG-UHFFFAOYSA-N 0.000 description 1
- SPSKFVHUUJWUPB-UHFFFAOYSA-N [4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]boronic acid Chemical compound O1C(C)=NN=C1C1=CC=C(B(O)O)C=C1 SPSKFVHUUJWUPB-UHFFFAOYSA-N 0.000 description 1
- OIZBAXXMKHGQPB-UHFFFAOYSA-N [4-(aminomethyl)piperidin-1-yl]-[2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-(2-methylphenyl)pyrazol-3-yl]methanone Chemical compound NCC1CCN(CC1)C(=O)C1=C(C(=NN1C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)C1=C(C=CC=C1)C OIZBAXXMKHGQPB-UHFFFAOYSA-N 0.000 description 1
- XUISQVPDUNMFRC-UHFFFAOYSA-N [4-(aminomethyl)piperidin-1-yl]-[4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazol-3-yl]methanone Chemical compound NCC1CCN(CC1)C(=O)C1=C(C(=NN1C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F XUISQVPDUNMFRC-UHFFFAOYSA-N 0.000 description 1
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 1
- ZUWPIXGMJSFNTN-UHFFFAOYSA-N [4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazol-3-yl]-[3-(diethylamino)pyrrolidin-1-yl]methanone Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N1CC(CC1)N(CC)CC)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F ZUWPIXGMJSFNTN-UHFFFAOYSA-N 0.000 description 1
- TXEPASFKYCLCSI-UHFFFAOYSA-N [4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazol-3-yl]-[4-(hydroxymethyl)piperidin-1-yl]methanone Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N1CCC(CC1)CO)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F TXEPASFKYCLCSI-UHFFFAOYSA-N 0.000 description 1
- YEQKNFWDLQVYLX-UHFFFAOYSA-N [4-[3,5-bis(trifluoromethyl)phenyl]-2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methylpyrazol-3-yl]-morpholin-4-ylmethanone Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C=1C(=NN(C=1C(=O)N1CCOCC1)C=1SC(=C(N=1)C1=CC(=C(C=C1)Cl)Cl)SC(C)C)C)(F)F YEQKNFWDLQVYLX-UHFFFAOYSA-N 0.000 description 1
- SWIHOHJBUZBINE-UHFFFAOYSA-N [4-chloro-3-(morpholine-4-carbonyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(C(=O)N2CCOCC2)=C1 SWIHOHJBUZBINE-UHFFFAOYSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000020990 adrenal cortex carcinoma Diseases 0.000 description 1
- 208000007128 adrenocortical carcinoma Diseases 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 201000007538 anal carcinoma Diseases 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000021780 appendiceal neoplasm Diseases 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- 208000024055 brain glioblastoma Diseases 0.000 description 1
- 201000011609 brain glioblastoma multiforme Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- GNVMUORYQLCPJZ-UHFFFAOYSA-N carbamothioic s-acid Chemical compound NC(S)=O GNVMUORYQLCPJZ-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000012054 celltiter-glo Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 201000007455 central nervous system cancer Diseases 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 208000011654 childhood malignant neoplasm Diseases 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004617 chromonyl group Chemical group O1C(=CC(C2=CC=CC=C12)=O)* 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000012650 click reaction Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 229940127113 compound 57 Drugs 0.000 description 1
- 229940125900 compound 59 Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- JGDFBJMWFLXCLJ-UHFFFAOYSA-N copper chromite Chemical compound [Cu]=O.[Cu]=O.O=[Cr]O[Cr]=O JGDFBJMWFLXCLJ-UHFFFAOYSA-N 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000012045 crude solution Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- 125000005051 dihydropyrazinyl group Chemical group N1(CC=NC=C1)* 0.000 description 1
- 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 125000005053 dihydropyrimidinyl group Chemical group N1(CN=CC=C1)* 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 208000024519 eye neoplasm Diseases 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 230000007946 glucose deprivation Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 201000009277 hairy cell leukemia Diseases 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 201000008298 histiocytosis Diseases 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 201000008893 intraocular retinoblastoma Diseases 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 201000002529 islet cell tumor Diseases 0.000 description 1
- 125000005990 isobenzothienyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical compound C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000002664 langerhans' cell Anatomy 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 208000026807 lung carcinoid tumor Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000012931 lyophilized formulation Substances 0.000 description 1
- 229940124302 mTOR inhibitor Drugs 0.000 description 1
- 201000000564 macroglobulinemia Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 201000003175 male breast cancer Diseases 0.000 description 1
- 208000010907 male breast carcinoma Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- VFUIDNWCLDZDTR-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1)N1N=C(C(=C1C(=O)OC)CC1=C(C=CC=C1)[N+](=O)[O-])C VFUIDNWCLDZDTR-UHFFFAOYSA-N 0.000 description 1
- JCOXVOVBFKLJSQ-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-5-ethylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SCC)N1N=C(C(=C1C(=O)OC)CC1=C(C=CC=C1)[N+](=O)[O-])C JCOXVOVBFKLJSQ-UHFFFAOYSA-N 0.000 description 1
- XDYUGVNSSGALFR-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-5-propan-2-ylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SC(C)C)N1N=C(C(=C1C(=O)OC)CC1=C(C=CC=C1)[N+](=O)[O-])C XDYUGVNSSGALFR-UHFFFAOYSA-N 0.000 description 1
- ZMUQIQNQGXPVCP-UHFFFAOYSA-N methyl 2-[4-(3,4-dichlorophenyl)-5-propylsulfanyl-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C=1N=C(SC=1SCCC)N1N=C(C(=C1C(=O)OC)CC1=C(C=CC=C1)[N+](=O)[O-])C ZMUQIQNQGXPVCP-UHFFFAOYSA-N 0.000 description 1
- UZZCSVANJZROOJ-UHFFFAOYSA-N methyl 2-[5-(3,4-dichlorophenyl)-1-(2-methylpropyl)-1,2,4-triazol-3-yl]-4-iodo-5-methylpyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1CC(C)C)N1N=C(C(=C1C(=O)OC)I)C UZZCSVANJZROOJ-UHFFFAOYSA-N 0.000 description 1
- NTFMLNKMYATCCT-UHFFFAOYSA-N methyl 2-[5-(3,4-dichlorophenyl)-1H-1,2,4-triazol-3-yl]-4-iodo-5-methylpyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1)N1N=C(C(=C1C(=O)OC)I)C NTFMLNKMYATCCT-UHFFFAOYSA-N 0.000 description 1
- WBXPRPKYEVKHRT-UHFFFAOYSA-N methyl 2-[5-(3,4-dichlorophenyl)-1H-1,2,4-triazol-3-yl]-5-methylpyrazole-3-carboxylate Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1)N1N=C(C=C1C(=O)OC)C WBXPRPKYEVKHRT-UHFFFAOYSA-N 0.000 description 1
- FXJWKBXZBSCNKY-UHFFFAOYSA-N methyl 2-[5-butan-2-ylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-4-(2,6-dimethylpyridin-4-yl)-5-methylpyrazole-3-carboxylate Chemical compound C(C)(CC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)C1=CC(=NC(=C1)C)C)C)C1=CC(=C(C=C1)Cl)Cl FXJWKBXZBSCNKY-UHFFFAOYSA-N 0.000 description 1
- MAGIWMNZKZNOJX-UHFFFAOYSA-N methyl 2-[5-butan-2-ylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-4-(3,5-dichlorophenyl)-5-methylpyrazole-3-carboxylate Chemical compound C(C)(CC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)C1=CC(=CC(=C1)Cl)Cl)C)C1=CC(=C(C=C1)Cl)Cl MAGIWMNZKZNOJX-UHFFFAOYSA-N 0.000 description 1
- AHLBSYOIGVUFSL-UHFFFAOYSA-N methyl 2-[5-butylsulfanyl-4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-5-methyl-4-[(2-nitrophenyl)methyl]pyrazole-3-carboxylate Chemical compound C(CCC)SC1=C(N=C(S1)N1N=C(C(=C1C(=O)OC)CC1=C(C=CC=C1)[N+](=O)[O-])C)C1=CC(=C(C=C1)Cl)Cl AHLBSYOIGVUFSL-UHFFFAOYSA-N 0.000 description 1
- WICGATIORFSOJL-UHFFFAOYSA-N methyl 3,4-dichlorobenzoate Chemical compound COC(=O)C1=CC=C(Cl)C(Cl)=C1 WICGATIORFSOJL-UHFFFAOYSA-N 0.000 description 1
- IBKQOAJWNVNVMC-UHFFFAOYSA-N methyl 4-bromo-2-[5-bromo-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]-5-methylpyrazole-3-carboxylate Chemical compound BrC=1C(=NN(C=1C(=O)OC)C=1SC(=C(N=1)C1=CC=C(C=C1)C(F)(F)F)Br)C IBKQOAJWNVNVMC-UHFFFAOYSA-N 0.000 description 1
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 201000006462 myelodysplastic/myeloproliferative neoplasm Diseases 0.000 description 1
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- PBDNOFLCGXVKLF-UHFFFAOYSA-N n-methoxyhydroxylamine;hydrochloride Chemical compound Cl.CONO PBDNOFLCGXVKLF-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 201000002575 ocular melanoma Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 201000008859 olfactory neuroblastoma Diseases 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- 230000006712 oncogenic signaling pathway Effects 0.000 description 1
- 201000006958 oropharynx cancer Diseases 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000006299 oxetan-3-yl group Chemical group [H]C1([H])OC([H])([H])C1([H])* 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 208000029211 papillomatosis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 208000007312 paraganglioma Diseases 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 1
- FSDNTQSJGHSJBG-UHFFFAOYSA-N piperidine-4-carbonitrile Chemical compound N#CC1CCNCC1 FSDNTQSJGHSJBG-UHFFFAOYSA-N 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- 208000010626 plasma cell neoplasm Diseases 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000016800 primary central nervous system lymphoma Diseases 0.000 description 1
- 230000009696 proliferative response Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000004620 quinolinyl-N-oxide group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical class C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000020129 regulation of cell death Effects 0.000 description 1
- 230000025053 regulation of cell proliferation Effects 0.000 description 1
- 208000030859 renal pelvis/ureter urothelial carcinoma Diseases 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 201000003804 salivary gland carcinoma Diseases 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000012363 selectfluor Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 201000008205 supratentorial primitive neuroectodermal tumor Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- PJHJCRVKOBJJLT-UHFFFAOYSA-N tert-butyl N-[[5-(3,4-dichlorophenyl)-1H-1,2,4-triazol-3-yl]amino]carbamate Chemical compound ClC=1C=C(C=CC=1Cl)C1=NC(=NN1)NNC(=O)OC(C)(C)C PJHJCRVKOBJJLT-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 208000008732 thymoma Diseases 0.000 description 1
- AKCRNFFTGXBONI-UHFFFAOYSA-N torin 1 Chemical compound C1CN(C(=O)CC)CCN1C1=CC=C(N2C(C=CC3=C2C2=CC(=CC=C2N=C3)C=2C=C3C=CC=CC3=NC=2)=O)C=C1C(F)(F)F AKCRNFFTGXBONI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000016596 traversing start control point of mitotic cell cycle Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 208000037965 uterine sarcoma Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000011531 vascular cancer Diseases 0.000 description 1
- 206010055031 vascular neoplasm Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428271P | 2016-11-30 | 2016-11-30 | |
| US62/428,271 | 2016-11-30 | ||
| CN201780084999.4A CN110603254B (zh) | 2016-11-30 | 2017-11-29 | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 |
| PCT/US2017/063774 WO2018102453A1 (en) | 2016-11-30 | 2017-11-29 | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780084999.4A Division CN110603254B (zh) | 2016-11-30 | 2017-11-29 | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118930533A true CN118930533A (zh) | 2024-11-12 |
Family
ID=62241871
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410345199.5A Pending CN118930533A (zh) | 2016-11-30 | 2017-11-29 | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 |
| CN201780084999.4A Active CN110603254B (zh) | 2016-11-30 | 2017-11-29 | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780084999.4A Active CN110603254B (zh) | 2016-11-30 | 2017-11-29 | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11325903B2 (https=) |
| EP (1) | EP3548482A4 (https=) |
| JP (1) | JP7373992B2 (https=) |
| CN (2) | CN118930533A (https=) |
| AU (1) | AU2017366901B2 (https=) |
| BR (1) | BR112019011044A2 (https=) |
| CA (1) | CA3081983A1 (https=) |
| IL (1) | IL266930B2 (https=) |
| MX (1) | MX2019006299A (https=) |
| WO (1) | WO2018102453A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7039489B2 (ja) | 2016-05-18 | 2022-03-22 | ミラティ セラピューティクス， インコーポレイテッド | Ｋｒａｓ ｇ１２ｃ阻害剤 |
| MX2019006296A (es) * | 2016-11-30 | 2019-11-12 | Bantam Pharmaceutical Llc | Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas. |
| AU2017366901B2 (en) * | 2016-11-30 | 2022-09-29 | Bantam Pharmaceutical, Llc | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases |
| US10647715B2 (en) | 2017-11-15 | 2020-05-12 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| HRP20230377T1 (hr) | 2017-11-15 | 2023-06-23 | Mirati Therapeutics, Inc. | Inhibitori mutacije kras g12c |
| US11932633B2 (en) | 2018-05-07 | 2024-03-19 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| WO2019236966A2 (en) | 2018-06-07 | 2019-12-12 | Bantam Pharmaceutical, Llc | Methods of treatment of cancer with substituted pyrrole and pyrazole compounds and diagnosis of cancers susceptible to treatment with substituted pyrrole and pyrazole compounds |
| JP2022500385A (ja) | 2018-09-10 | 2022-01-04 | ミラティ セラピューティクス， インコーポレイテッド | 組み合わせ療法 |
| WO2020055761A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| SMT202500028T1 (it) | 2018-09-10 | 2025-03-12 | Mirati Therapeutics Inc | Terapie combinate |
| CA3112043A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| CN113164418A (zh) | 2018-12-05 | 2021-07-23 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| WO2020146613A1 (en) | 2019-01-10 | 2020-07-16 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| EP3976606A1 (en) * | 2019-05-31 | 2022-04-06 | Bantam Pharmaceutical, LLC | Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative |
| WO2020243582A1 (en) | 2019-05-31 | 2020-12-03 | Bantam Pharmaceutical, Llc | Methods for making thiszolylpyrazole carboxylic acids and intermediates therefor |
| WO2021041671A1 (en) | 2019-08-29 | 2021-03-04 | Mirati Therapeutics, Inc. | Kras g12d inhibitors |
| CN114761012B (zh) | 2019-09-24 | 2025-03-21 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| PH12022551513A1 (en) | 2019-12-20 | 2023-04-24 | Mirati Therapeutics Inc | Sos1 inhibitors |
| WO2021245055A1 (en) * | 2020-06-02 | 2021-12-09 | Boehringer Ingelheim International Gmbh | Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer |
| WO2022056307A1 (en) | 2020-09-11 | 2022-03-17 | Mirati Therapeutics, Inc. | Crystalline forms of a kras g12c inhibitor |
| WO2022132200A1 (en) | 2020-12-15 | 2022-06-23 | Mirati Therapeutics, Inc. | Azaquinazoline pan-kras inhibitors |
| EP4262803A4 (en) | 2020-12-16 | 2025-03-12 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-kras inhibitors |
| US20250313553A1 (en) * | 2021-12-01 | 2025-10-09 | Boehringer Ingelheim Int'l GmbH Corp. | Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer |
| WO2023099624A1 (en) | 2021-12-01 | 2023-06-08 | Boehringer Ingelheim International Gmbh | Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer |
| CN116678810A (zh) * | 2022-02-23 | 2023-09-01 | 武汉市鼎华双雄生物科技有限责任公司 | 细胞增殖免疫荧光检测试剂盒及其应用 |
| CN117003651B (zh) * | 2023-09-28 | 2024-01-02 | 广东嘉博制药有限公司 | 一种l-肾上腺素的制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1301968B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Derivati di eritromicina ad attivita' antibiotica |
| DE60006057T2 (de) | 1999-12-03 | 2004-05-27 | Pfizer Products Inc., Groton | Heteroarylphenylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel |
| US6900219B2 (en) | 2002-04-04 | 2005-05-31 | Cv Therapeutics, Inc. | ABCA-1 elevating compounds |
| AU2004228057A1 (en) * | 2003-04-03 | 2004-10-21 | Merck & Co., Inc. | Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| EP1618099A4 (en) | 2003-04-18 | 2008-07-16 | Merck & Co Inc | BIARYLSUBSTITUTED DIAZOLE, OXAZOLE AND IMIDAZOLE AS SODIUM CHANNEL BLOCKERS |
| WO2007138110A2 (en) | 2006-06-01 | 2007-12-06 | Devgen N.V. | Compounds that interact with ion channels, in particular with ion channels from the kv family |
| WO2008121861A2 (en) | 2007-03-28 | 2008-10-09 | Xenon Pharmaceuticals Inc. | Pyrazole and pyrrole compounds useful in treating iron disorders |
| US8642597B2 (en) | 2007-08-27 | 2014-02-04 | Basf Se | Pyrazole compounds for controlling invertebrate pests |
| CN102056907B (zh) | 2008-04-04 | 2014-12-31 | 武田药品工业株式会社 | 杂环衍生物及其用途 |
| SI2275414T1 (sl) | 2008-04-28 | 2015-10-30 | Kyorin Pharmaceutical Co., Ltd., | Ciklopentilakrilamidni derivat |
| US9409901B2 (en) * | 2012-10-22 | 2016-08-09 | Bantam Pharmaceutical, Llc | Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E |
| JP6434989B2 (ja) | 2014-03-27 | 2018-12-05 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ピリジルピペリジン |
| US10125139B2 (en) | 2015-04-24 | 2018-11-13 | Syngenta Crop Protection Ag | Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocycles |
| EP3303332A1 (en) * | 2015-06-01 | 2018-04-11 | Bantam Pharmaceutical, LLC | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto |
| AU2017366901B2 (en) * | 2016-11-30 | 2022-09-29 | Bantam Pharmaceutical, Llc | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases |
| MX2019006296A (es) | 2016-11-30 | 2019-11-12 | Bantam Pharmaceutical Llc | Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas. |
| EP3976606A1 (en) * | 2019-05-31 | 2022-04-06 | Bantam Pharmaceutical, LLC | Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative |
-
2017
- 2017-11-29 AU AU2017366901A patent/AU2017366901B2/en active Active
- 2017-11-29 CA CA3081983A patent/CA3081983A1/en active Pending
- 2017-11-29 US US16/465,136 patent/US11325903B2/en active Active
- 2017-11-29 JP JP2019528861A patent/JP7373992B2/ja active Active
- 2017-11-29 EP EP17876486.6A patent/EP3548482A4/en active Pending
- 2017-11-29 WO PCT/US2017/063774 patent/WO2018102453A1/en not_active Ceased
- 2017-11-29 CN CN202410345199.5A patent/CN118930533A/zh active Pending
- 2017-11-29 BR BR112019011044-5A patent/BR112019011044A2/pt active IP Right Grant
- 2017-11-29 MX MX2019006299A patent/MX2019006299A/es unknown
- 2017-11-29 IL IL266930A patent/IL266930B2/en unknown
- 2017-11-29 CN CN201780084999.4A patent/CN110603254B/zh active Active
-
2022
- 2022-05-10 US US17/741,153 patent/US20230076820A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL266930B1 (en) | 2025-05-01 |
| MX2019006299A (es) | 2019-11-12 |
| RU2019120233A (ru) | 2021-01-11 |
| AU2017366901A1 (en) | 2019-07-11 |
| CN110603254A (zh) | 2019-12-20 |
| CA3081983A1 (en) | 2018-06-07 |
| JP2019536785A (ja) | 2019-12-19 |
| NZ754827A (en) | 2025-10-31 |
| US20230076820A1 (en) | 2023-03-09 |
| IL266930A (en) | 2019-07-31 |
| EP3548482A1 (en) | 2019-10-09 |
| RU2019120233A3 (https=) | 2021-03-11 |
| US11325903B2 (en) | 2022-05-10 |
| WO2018102453A1 (en) | 2018-06-07 |
| US20190345152A1 (en) | 2019-11-14 |
| EP3548482A4 (en) | 2020-08-19 |
| BR112019011044A2 (pt) | 2019-10-08 |
| JP7373992B2 (ja) | 2023-11-06 |
| IL266930B2 (en) | 2025-09-01 |
| CN110603254B (zh) | 2024-04-12 |
| AU2017366901B2 (en) | 2022-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110603254B (zh) | 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法 | |
| KR102680164B1 (ko) | Rock 억제제로서의 페닐아세트아미드 | |
| US12150934B2 (en) | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases | |
| US9255089B2 (en) | Benzimidazolone derivatives as bromodomain inhibitors | |
| CN109906227B (zh) | 8,9-二氢咪唑[1,2-a]嘧啶并[5,4-e]嘧啶-5(6H)-酮类化合物 | |
| CN113544128A (zh) | Kras-g12c抑制剂 | |
| TW202144345A (zh) | Ｋｒａｓ突變蛋白抑制劑 | |
| RU2559895C2 (ru) | Азотосодержащие производные гетероарилов | |
| AU2006297948A1 (en) | Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders | |
| US9475817B2 (en) | Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors | |
| EP2396325B1 (en) | Derivatives of azaindoles as inhibitors of protein kinases abl and src | |
| KR20190098266A (ko) | 치환된 축합 헤테로아릴기 화합물인 키나제 억제제 및 이의 응용 | |
| JP2009520791A (ja) | 酵素阻害剤 | |
| EP4642767A1 (en) | Pyrimidine carboxamide compounds | |
| JP2024534208A (ja) | Ｐａｒｐ７阻害剤及びその使用 | |
| KR20230022861A (ko) | Tead 결합제로서 유용한 트리시클릭 헤테로사이클 | |
| RU2787994C2 (ru) | Замещенные соединения пиразола и способы их применения для лечения гиперпролиферативных заболеваний | |
| HK40083035B (zh) | Parp7抑制剂及其用途 | |
| HK1220692B (en) | Benzimidazolone derivatives as bromodomain inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |